US5831066A
(en)
*
|
1988-12-22 |
1998-11-03 |
The Trustees Of The University Of Pennsylvania |
Regulation of bcl-2 gene expression
|
US5639595A
(en)
*
|
1990-05-01 |
1997-06-17 |
Isis Phamaceuticals, Inc. |
Identification of novel drugs and reagents
|
US5723289A
(en)
*
|
1990-06-11 |
1998-03-03 |
Nexstar Pharmaceuticals, Inc. |
Parallel selex
|
US6168778B1
(en)
|
1990-06-11 |
2001-01-02 |
Nexstar Pharmaceuticals, Inc. |
Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes
|
US5629155A
(en)
*
|
1990-06-11 |
1997-05-13 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to immunoglobulin E (IgE)
|
US5476766A
(en)
*
|
1990-06-11 |
1995-12-19 |
Nexstar Pharmaceuticals, Inc. |
Ligands of thrombin
|
US6716580B2
(en)
*
|
1990-06-11 |
2004-04-06 |
Somalogic, Inc. |
Method for the automated generation of nucleic acid ligands
|
US5780228A
(en)
*
|
1990-06-11 |
1998-07-14 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands to lectins
|
US6395888B1
(en)
|
1996-02-01 |
2002-05-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands of complement system proteins
|
US6344321B1
(en)
*
|
1990-06-11 |
2002-02-05 |
Gilead Sciences, Inc. |
Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met
|
US6001988A
(en)
*
|
1990-06-11 |
1999-12-14 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands to lectins
|
US20060084797A1
(en)
*
|
1990-06-11 |
2006-04-20 |
Gilead Sciences, Inc. |
High affinity TGFbeta nucleic acid ligands and inhibitors
|
US5580737A
(en)
*
|
1990-06-11 |
1996-12-03 |
Nexstar Pharmaceuticals, Inc. |
High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
|
US6465189B1
(en)
|
1990-06-11 |
2002-10-15 |
Gilead Sciences, Inc. |
Systematic evolution of ligands by exponential enrichment: blended selex
|
US5496938A
(en)
*
|
1990-06-11 |
1996-03-05 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to HIV-RT and HIV-1 rev
|
US6083696A
(en)
*
|
1990-06-11 |
2000-07-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands exponential enrichment: blended selex
|
US5972599A
(en)
|
1990-06-11 |
1999-10-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of cytokines
|
US5472841A
(en)
*
|
1990-06-11 |
1995-12-05 |
Nexstar Pharmaceuticals, Inc. |
Methods for identifying nucleic acid ligands of human neutrophil elastase
|
US5705337A
(en)
*
|
1990-06-11 |
1998-01-06 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
|
US5674685A
(en)
*
|
1990-06-11 |
1997-10-07 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
US6147204A
(en)
*
|
1990-06-11 |
2000-11-14 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand complexes
|
US6759392B1
(en)
*
|
1990-06-11 |
2004-07-06 |
Gilead Sciences, Inc. |
High affinity RNA ligands of basic fibroblast growth factor
|
US6261774B1
(en)
|
1990-06-11 |
2001-07-17 |
Gilead Sciences, Inc. |
Truncation selex method
|
US5686592A
(en)
*
|
1990-06-11 |
1997-11-11 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to immunoglobulin E (IgE)
|
US20040132067A1
(en)
*
|
1990-06-11 |
2004-07-08 |
Somalogic, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
US6280932B1
(en)
|
1990-06-11 |
2001-08-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands to lectins
|
US5637682A
(en)
*
|
1990-06-11 |
1997-06-10 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to the tachykinin substance P
|
US5707796A
(en)
*
|
1990-06-11 |
1998-01-13 |
Nexstar Pharmaceuticals, Inc. |
Method for selecting nucleic acids on the basis of structure
|
US6331394B1
(en)
|
1991-06-10 |
2001-12-18 |
Gilead Sciences, Inc. |
Nucleic acid ligands to integrins
|
US6465188B1
(en)
*
|
1990-06-11 |
2002-10-15 |
Gilead Sciences, Inc. |
Nucleic acid ligand complexes
|
US5766853A
(en)
*
|
1990-06-11 |
1998-06-16 |
Nexstar Pharmaceuticals, Inc. |
Method for identification of high affinity nucleic acid ligands to selectins
|
US5637459A
(en)
*
|
1990-06-11 |
1997-06-10 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chimeric selex
|
US5635615A
(en)
*
|
1990-06-11 |
1997-06-03 |
Nexstar Pharmaceuticals, Inc. |
High affinity HIV nucleocapsid nucleic acid ligands
|
US6569620B1
(en)
*
|
1990-06-11 |
2003-05-27 |
Somalogic, Inc. |
Method for the automated generation of nucleic acid ligands
|
US5869641A
(en)
*
|
1990-06-11 |
1999-02-09 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of CD4
|
US5660985A
(en)
*
|
1990-06-11 |
1997-08-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands containing modified nucleotides
|
US6177557B1
(en)
|
1990-06-11 |
2001-01-23 |
Nexstar Pharmaceuticals, Inc. |
High affinity ligands of basic fibroblast growth factor and thrombin
|
US5864026A
(en)
*
|
1990-06-11 |
1999-01-26 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
US6030776A
(en)
*
|
1990-06-11 |
2000-02-29 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX
|
US6011020A
(en)
*
|
1990-06-11 |
2000-01-04 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand complexes
|
US5587468A
(en)
*
|
1990-06-11 |
1996-12-24 |
University Research Corporation |
High affinity nucleic acid ligands to HIV integrase
|
WO1996034876A1
(fr)
|
1995-05-04 |
1996-11-07 |
Nexstar Pharmaceuticals, Inc. |
Complexes de ligands d'acide nucleique
|
US5683867A
(en)
*
|
1990-06-11 |
1997-11-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: blended SELEX
|
US5503978A
(en)
*
|
1990-06-11 |
1996-04-02 |
University Research Corporation |
Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase
|
US5648214A
(en)
*
|
1990-06-11 |
1997-07-15 |
University Research Corporation |
High-affinity oligonucleotide ligands to the tachykinin substance P
|
US6001577A
(en)
|
1998-06-08 |
1999-12-14 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
US5795721A
(en)
*
|
1990-06-11 |
1998-08-18 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of ICP4
|
US5962219A
(en)
|
1990-06-11 |
1999-10-05 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-selex
|
US5861254A
(en)
*
|
1997-01-31 |
1999-01-19 |
Nexstar Pharmaceuticals, Inc. |
Flow cell SELEX
|
US5668264A
(en)
*
|
1990-06-11 |
1997-09-16 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
US6232071B1
(en)
|
1990-06-11 |
2001-05-15 |
Gilead Sciences, Inc. |
Tenascin-C nucleic acid ligands
|
US5849890A
(en)
*
|
1990-06-11 |
1998-12-15 |
Nexstar Pharmaceuticals, Inc. |
High affinity oligonucleotide ligands to chorionic gonadotropin hormone and related glycoprotein hormones
|
US5654151A
(en)
*
|
1990-06-11 |
1997-08-05 |
Nexstar Pharmaceuticals, Inc. |
High affinity HIV Nucleocapsid nucleic acid ligands
|
US6346611B1
(en)
|
1990-06-11 |
2002-02-12 |
Gilead Sciences, Inc. |
High affinity TGfβ nucleic acid ligands and inhibitors
|
US5843701A
(en)
*
|
1990-08-02 |
1998-12-01 |
Nexstar Pharmaceticals, Inc. |
Systematic polypeptide evolution by reverse translation
|
WO1992005285A1
(fr)
*
|
1990-09-21 |
1992-04-02 |
Fred Hutchinson Cancer Research Center |
Sequences d'oligonucleotides specifiques de sequences de proteines
|
CA2104698A1
(fr)
*
|
1991-02-21 |
1992-08-22 |
John J. Toole |
Aptameres specifiques de biomolecules et methodes de production
|
US5840867A
(en)
*
|
1991-02-21 |
1998-11-24 |
Gilead Sciences, Inc. |
Aptamer analogs specific for biomolecules
|
US6762290B1
(en)
*
|
1999-07-29 |
2004-07-13 |
Gilead Sciences, Inc. |
High affinity vascular endothelial growth factor (VEGF) receptor nucleic acid ligands and inhibitors
|
US5582981A
(en)
*
|
1991-08-14 |
1996-12-10 |
Gilead Sciences, Inc. |
Method for identifying an oligonucleotide aptamer specific for a target
|
AU2580892A
(en)
*
|
1991-09-05 |
1993-04-05 |
Isis Pharmaceuticals, Inc. |
Determination of oligonucleotides for therapeutics, diagnostics and research reagents
|
EP0623141A1
(fr)
*
|
1992-01-13 |
1994-11-09 |
The President And Fellows Of Harvard College |
Selection de molecules de liaison
|
US5783384A
(en)
*
|
1992-01-13 |
1998-07-21 |
President And Fellows Of Harvard College |
Selection of binding-molecules
|
US20040127446A1
(en)
*
|
1992-05-14 |
2004-07-01 |
Lawrence Blatt |
Oligonucleotide mediated inhibition of hepatitis B virus and hepatitis C virus replication
|
US5756291A
(en)
*
|
1992-08-21 |
1998-05-26 |
Gilead Sciences, Inc. |
Aptamers specific for biomolecules and methods of making
|
US6582902B1
(en)
|
1992-09-30 |
2003-06-24 |
Jack D. Keene |
Method for deriving epitopes
|
WO1994006934A1
(fr)
*
|
1992-09-11 |
1994-03-31 |
Duke University |
Procede de derivation des epitopes
|
EP0668931B1
(fr)
*
|
1992-09-29 |
2006-01-04 |
Gilead Sciences, Inc. |
Ligands d'acide nucleique et procedes de production
|
AU5442194A
(en)
*
|
1992-10-14 |
1994-05-09 |
University Research Corporation |
Method for selecting nucleic acids on the basis of structure
|
US5998142A
(en)
*
|
1993-09-08 |
1999-12-07 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
|
WO1995007364A1
(fr)
*
|
1993-09-08 |
1995-03-16 |
Nexstar Pharmaceuticals, Inc. |
Acides nucleiques servant de ligands et procedes de production ameliores
|
EP1889910A3
(fr)
*
|
1993-09-17 |
2009-09-02 |
SomaLogic, Inc. |
Évolution systématique de ligands par enrichissement exponentiel: photosélection de ligands d'acide nucléique et selex en solution
|
US6458539B1
(en)
*
|
1993-09-17 |
2002-10-01 |
Somalogic, Inc. |
Photoselection of nucleic acid ligands
|
JPH09506629A
(ja)
*
|
1993-12-17 |
1997-06-30 |
キュビッチョッティ,ロジャー・エス |
ヌクレオチドに支配された生体分子および多分子薬物の集合並びに装置
|
GB9401833D0
(en)
*
|
1994-02-01 |
1994-03-30 |
Isis Innovation |
Method for discovering ligands
|
US7153948B2
(en)
|
1994-04-25 |
2006-12-26 |
Gilead Sciences, Inc. |
High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
|
US20020077306A1
(en)
*
|
1994-07-14 |
2002-06-20 |
Ludger Dinkelborg |
Conjugates made of metal complexes and oligonucleotides, agents containing the conjugates, their use in radiodiagnosis as well as process for their production
|
IL114237A
(en)
*
|
1994-07-14 |
2000-08-31 |
Schering Ag |
Oligonucleotide conjugates and diagnostic processes utilizing the same
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6048698A
(en)
*
|
1994-09-20 |
2000-04-11 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX™
|
US5663064A
(en)
*
|
1995-01-13 |
1997-09-02 |
University Of Vermont |
Ribozymes with RNA protein binding site
|
AU5301996A
(en)
*
|
1995-03-06 |
1996-09-23 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to secretory phospholipase a2(spla2)
|
AU732961B2
(en)
*
|
1995-05-03 |
2001-05-03 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
ATE276266T1
(de)
|
1995-05-03 |
2004-10-15 |
Gilead Sciences Inc |
Nukleinsäureliganden für gewebeziele
|
US6013443A
(en)
|
1995-05-03 |
2000-01-11 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue SELEX
|
US8071737B2
(en)
*
|
1995-05-04 |
2011-12-06 |
Glead Sciences, Inc. |
Nucleic acid ligand complexes
|
US5859228A
(en)
*
|
1995-05-04 |
1999-01-12 |
Nexstar Pharmaceuticals, Inc. |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
JP5637528B2
(ja)
*
|
1995-05-04 |
2014-12-10 |
ギリード・サイエンシズ・インコーポレーテッド |
核酸リガンド複合体
|
US5723594A
(en)
*
|
1995-06-07 |
1998-03-03 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
JP4335975B2
(ja)
*
|
1995-06-07 |
2009-09-30 |
ギリード・サイエンシズ・インコーポレーテッド |
Dnaポリメラーゼに対する結合・阻害核酸リガンド
|
US6229002B1
(en)
|
1995-06-07 |
2001-05-08 |
Nexstar Pharmaceuticlas, Inc. |
Platelet derived growth factor (PDGF) nucleic acid ligand complexes
|
US6183967B1
(en)
|
1995-06-07 |
2001-02-06 |
Nexstar Pharmaceuticals |
Nucleic acid ligand inhibitors to DNA polymerases
|
US6699843B2
(en)
|
1995-06-07 |
2004-03-02 |
Gilead Sciences, Inc. |
Method for treatment of tumors using nucleic acid ligands to PDGF
|
US20090118481A1
(en)
*
|
1995-06-07 |
2009-05-07 |
Gilead Sciences, Inc. |
High Affinity Nucleic Acid Ligands To Lectins
|
US20040220128A1
(en)
*
|
1995-10-26 |
2004-11-04 |
Sirna Therapeutics, Inc. |
Nucleic acid based modulation of female reproductive diseases and conditions
|
US20040102389A1
(en)
*
|
1995-10-26 |
2004-05-27 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid-mediated treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)
|
US20040142895A1
(en)
*
|
1995-10-26 |
2004-07-22 |
Sirna Therapeutics, Inc. |
Nucleic acid-based modulation of gene expression in the vascular endothelial growth factor pathway
|
DE19543750C2
(de)
*
|
1995-11-24 |
1997-10-23 |
Crinos Industria Farmaco |
Cathepsin G inhibierende Aptamere
|
US20020106647A1
(en)
*
|
1996-07-24 |
2002-08-08 |
Segal Andrew H. |
Nucleic acid compositions and methods of introducing nucleic acids into cells
|
US20020022227A1
(en)
*
|
1996-10-17 |
2002-02-21 |
Short Jay M. |
Morphatides: novel shape and structure libraries
|
US6838238B1
(en)
|
1996-10-17 |
2005-01-04 |
Invitrogen Corporation |
Morphatides: novel shape and structure libraries
|
US6051698A
(en)
*
|
1997-06-06 |
2000-04-18 |
Janjic; Nebojsa |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
US6426335B1
(en)
*
|
1997-10-17 |
2002-07-30 |
Gilead Sciences, Inc. |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
WO1998030575A1
(fr)
|
1997-01-08 |
1998-07-16 |
Proligo Llc |
Bioconjugaison de macromolecules
|
WO1998032880A1
(fr)
|
1997-01-23 |
1998-07-30 |
Immusol Incorporated |
Analyse fonctionnelle et decouverte de genes a l'aide de banques de vecteurs de genes de ribozymes specifiques a une cible ou bien rendues aleatoires
|
WO1999067423A1
(fr)
*
|
1998-06-22 |
1999-12-29 |
The Regents Of The University Of California |
Detecteurs colorimetriques de substances a analyser couples a des acides nucleiques
|
US6143496A
(en)
|
1997-04-17 |
2000-11-07 |
Cytonix Corporation |
Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
|
US5834199A
(en)
*
|
1997-04-29 |
1998-11-10 |
North Carolina State University |
Methods of identifying transition metal complexes that selectively cleave regulatory elements of mRNA and uses thereof
|
CA2220785A1
(fr)
*
|
1997-12-02 |
1999-06-02 |
Noureddine Rouissi |
Technique selective d'identification rapide des proteines et des genes et usages pertinents
|
US6242246B1
(en)
|
1997-12-15 |
2001-06-05 |
Somalogic, Inc. |
Nucleic acid ligand diagnostic Biochip
|
US20070166741A1
(en)
|
1998-12-14 |
2007-07-19 |
Somalogic, Incorporated |
Multiplexed analyses of test samples
|
US6268131B1
(en)
|
1997-12-15 |
2001-07-31 |
Sequenom, Inc. |
Mass spectrometric methods for sequencing nucleic acids
|
US6261783B1
(en)
|
1997-12-15 |
2001-07-17 |
Gilead Sciences, Inc. |
Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
|
US5989823A
(en)
|
1998-09-18 |
1999-11-23 |
Nexstar Pharmaceuticals, Inc. |
Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
|
AU2018999A
(en)
|
1997-12-31 |
1999-07-19 |
Medical College Of Georgia Research Institute, Inc. |
Oligomers that bind to ku protein
|
DE19800899A1
(de)
*
|
1998-01-13 |
1999-07-15 |
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh |
Oligoliganden mit Bindungsvermögen etc.
|
US6537747B1
(en)
|
1998-02-03 |
2003-03-25 |
Lucent Technologies Inc. |
Data transmission using DNA oligomers
|
US7393529B2
(en)
*
|
1998-04-09 |
2008-07-01 |
Idexx Laboratories, Inc. |
Methods and compositions for inhibiting binding of IgE to a high affinity receptor
|
US6180348B1
(en)
|
1998-04-20 |
2001-01-30 |
Weihua Li |
Method of isolating target specific oligonucleotide ligands
|
US6287765B1
(en)
*
|
1998-05-20 |
2001-09-11 |
Molecular Machines, Inc. |
Methods for detecting and identifying single molecules
|
US6225063B1
(en)
|
1998-05-22 |
2001-05-01 |
University Technology Corporation |
RNA channels in biological membranes
|
EP2045334A1
(fr)
|
1998-06-24 |
2009-04-08 |
Illumina, Inc. |
Décodage de capteurs de réseau avec des microsphères
|
US6100035A
(en)
|
1998-07-14 |
2000-08-08 |
Cistem Molecular Corporation |
Method of identifying cis acting nucleic acid elements
|
US20040259079A1
(en)
*
|
1998-07-22 |
2004-12-23 |
Immusol, Inc. |
Substantially complete ribozyme libraries
|
US6399302B1
(en)
*
|
1998-08-21 |
2002-06-04 |
University Of Virginia Patent Foundation |
Signal generating oligonucleotide-based biosensor
|
US20040242521A1
(en)
*
|
1999-10-25 |
2004-12-02 |
Board Of Regents, The University Of Texas System |
Thio-siRNA aptamers
|
US20060172925A1
(en)
*
|
1998-10-26 |
2006-08-03 |
Board Of Regents, The University Of Texas System |
Thio-siRNA aptamers
|
US6423493B1
(en)
*
|
1998-10-26 |
2002-07-23 |
Board Of Regents The University Of Texas System |
Combinatorial selection of oligonucleotide aptamers
|
EP1002875A1
(fr)
*
|
1998-11-17 |
2000-05-24 |
Mira Diagnostica GmbH |
Inhibiteur oligonucleotidique de polymérase thermostable
|
US6927024B2
(en)
*
|
1998-11-30 |
2005-08-09 |
Genentech, Inc. |
PCR assay
|
US7666609B1
(en)
*
|
1998-12-01 |
2010-02-23 |
Shanghai Cp Guojian Pharmaceutical Co. Ltd. |
Method and composition for diagnosis of melanocytic lesions
|
US6429027B1
(en)
|
1998-12-28 |
2002-08-06 |
Illumina, Inc. |
Composite arrays utilizing microspheres
|
US6858390B2
(en)
*
|
1998-12-31 |
2005-02-22 |
Ingeneus Corporation |
Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes
|
US20030054360A1
(en)
*
|
1999-01-19 |
2003-03-20 |
Larry Gold |
Method and apparatus for the automated generation of nucleic acid ligands
|
CA2259745A1
(fr)
*
|
1999-01-19 |
2000-07-19 |
Guy Tremblay |
Generation representative des genomes d'une banque d'oligonucleotides d"armn d'expression (cdnas) et leur utilisation
|
CA2360748A1
(fr)
*
|
1999-01-19 |
2000-07-27 |
Larry Gold |
Procede et dispositif de production automatisee de ligands d'acide nucleique
|
US6329145B1
(en)
|
1999-02-09 |
2001-12-11 |
Gilead Science, Inc. |
Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligand
|
US7189506B1
(en)
|
1999-03-03 |
2007-03-13 |
Genelabs Technologies, Inc. |
DNA binding compound-mediated molecular switch system
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
US20030215821A1
(en)
*
|
1999-04-20 |
2003-11-20 |
Kevin Gunderson |
Detection of nucleic acid reactions on bead arrays
|
US20060275782A1
(en)
|
1999-04-20 |
2006-12-07 |
Illumina, Inc. |
Detection of nucleic acid reactions on bead arrays
|
DK1923471T3
(da)
|
1999-04-20 |
2013-04-02 |
Illumina Inc |
Detektion af nukleinsyrereaktioner på bead-arrays
|
US6680377B1
(en)
*
|
1999-05-14 |
2004-01-20 |
Brandeis University |
Nucleic acid-based detection
|
US8080380B2
(en)
|
1999-05-21 |
2011-12-20 |
Illumina, Inc. |
Use of microfluidic systems in the detection of target analytes using microsphere arrays
|
US8481268B2
(en)
|
1999-05-21 |
2013-07-09 |
Illumina, Inc. |
Use of microfluidic systems in the detection of target analytes using microsphere arrays
|
US8137906B2
(en)
|
1999-06-07 |
2012-03-20 |
Sloning Biotechnology Gmbh |
Method for the synthesis of DNA fragments
|
US7074586B1
(en)
|
1999-06-17 |
2006-07-11 |
Source Precision Medicine, Inc. |
Quantitative assay for low abundance molecules
|
US6280943B1
(en)
|
1999-06-17 |
2001-08-28 |
Gilead Sciences, Inc. |
2′-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands
|
AU1429401A
(en)
|
1999-07-02 |
2001-02-05 |
Conceptual Mindworks, Inc. |
Organic semiconductor recognition complex and system
|
US6387620B1
(en)
*
|
1999-07-28 |
2002-05-14 |
Gilead Sciences, Inc. |
Transcription-free selex
|
US6171795B1
(en)
*
|
1999-07-29 |
2001-01-09 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to CD40ligand
|
US7005260B1
(en)
|
2000-01-28 |
2006-02-28 |
Gilead Sciences, Inc. |
Tenascin-C nucleic acid ligands
|
US6506887B1
(en)
*
|
1999-07-29 |
2003-01-14 |
Somalogic, Incorporated |
Conditional-selex
|
BR0003768A
(pt)
*
|
1999-08-26 |
2001-07-03 |
Tomas Antonio Santa Coloma |
Oligocorpos monoclonais e policlonais (reagentes sintéticos semelhantes a anticorpos baseados em oligonucleotìdeos) e um método de produção dos oligocorpos
|
ATE397672T1
(de)
|
1999-11-24 |
2008-06-15 |
Univ New York State Res Found |
Katalytische rnas mit aminoacylierender aktivität
|
US6558911B1
(en)
|
1999-12-10 |
2003-05-06 |
Oregon Health Sciences University |
Sperm quality assay
|
CA2328356A1
(fr)
*
|
1999-12-22 |
2001-06-22 |
Itty Atcravi |
Vehicules recreatifs
|
US7645743B2
(en)
*
|
1999-12-22 |
2010-01-12 |
Altermune, Llc |
Chemically programmable immunity
|
US20030087265A1
(en)
*
|
2000-01-21 |
2003-05-08 |
Edward Sauter |
Specific microarrays for breast cancer screening
|
AU2001229637A1
(en)
*
|
2000-01-21 |
2001-07-31 |
Thomas Jefferson University |
Nipple aspirate fluid specific microarrays
|
US7285384B2
(en)
|
2000-02-16 |
2007-10-23 |
Illuminia, Inc. |
Parallel genotyping of multiple patient samples
|
US20040023292A1
(en)
*
|
2001-10-19 |
2004-02-05 |
Mcswiggen James |
Method and reagent for the detection of proteins and peptides
|
JP2004500109A
(ja)
|
2000-03-22 |
2004-01-08 |
クァンタム・ドット・コーポレイション |
ビーズベースの核酸アッセイにおける半導体ナノクリスタルの使用方法
|
US7129326B2
(en)
*
|
2000-04-14 |
2006-10-31 |
Genencor International, Inc. |
Methods for selective targeting
|
ES2338097T3
(es)
*
|
2000-04-14 |
2010-05-04 |
Genencor International, Inc. |
Procedimiento de identificacion selectiva.
|
US7682837B2
(en)
*
|
2000-05-05 |
2010-03-23 |
Board Of Trustees Of Leland Stanford Junior University |
Devices and methods to form a randomly ordered array of magnetic beads and uses thereof
|
US6471968B1
(en)
|
2000-05-12 |
2002-10-29 |
Regents Of The University Of Michigan |
Multifunctional nanodevice platform
|
US8914114B2
(en)
|
2000-05-23 |
2014-12-16 |
The Feinstein Institute For Medical Research |
Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
|
US20020155084A1
(en)
*
|
2000-06-02 |
2002-10-24 |
The Regents Of The University Of The Michigan |
Nanoemulsion formulations
|
US20030207271A1
(en)
*
|
2000-06-30 |
2003-11-06 |
Holwitt Eric A. |
Methods and compositions for biological sensors
|
US7892484B2
(en)
*
|
2000-06-30 |
2011-02-22 |
Conceptual Mindworks, Inc. |
Methods and compositions for neutralizing anthrax and other bioagents
|
WO2002006827A1
(fr)
*
|
2000-07-05 |
2002-01-24 |
The General Hospital Corporation |
Composes et procedes permettant un etiquetage fluorescent d'acides nucleiques
|
US6376190B1
(en)
|
2000-09-22 |
2002-04-23 |
Somalogic, Inc. |
Modified SELEX processes without purified protein
|
AU9630501A
(en)
*
|
2000-09-26 |
2002-04-08 |
Univ Duke |
Rna aptamers and methods for identifying the same
|
DE10049074A1
(de)
*
|
2000-10-02 |
2002-04-18 |
Andreas Kage |
Verfahren zur Selektion hochaffin an ein Target bindender Nukleinsäuren
|
DE10048944A1
(de)
*
|
2000-10-03 |
2002-04-18 |
Andreas Kage |
Verfahren zur Selektion hochaffin an ein Target bindender Nukleinsäuren durch zweidimensionale Auftrennung
|
US20050059031A1
(en)
|
2000-10-06 |
2005-03-17 |
Quantum Dot Corporation |
Method for enhancing transport of semiconductor nanocrystals across biological membranes
|
EP2085781B2
(fr)
|
2000-10-06 |
2020-03-11 |
Life Technologies Corporation |
Cellules dotées d'une signature spectrale et leurs procédés de préparation et leur utilisation
|
CA2425605A1
(fr)
|
2000-10-16 |
2002-04-25 |
Gilead Sciences, Inc. |
Ligands d'acides nucleiques de l'antigene membranaire prostatique specifique
|
US20050054942A1
(en)
|
2002-01-22 |
2005-03-10 |
Melker Richard J. |
System and method for therapeutic drug monitoring
|
JP4379561B2
(ja)
*
|
2001-01-30 |
2009-12-09 |
キヤノンファインテック株式会社 |
シート処理装置及びこれを備えた画像形成装置
|
US7115369B2
(en)
*
|
2001-03-15 |
2006-10-03 |
Iowa State University Research Foundation, Inc. |
Functional nucleic acid probes and uses thereof
|
WO2002074978A2
(fr)
|
2001-03-19 |
2002-09-26 |
President And Fellows Of Harvard College |
Rearrangement de l'acide nucleique
|
US7807408B2
(en)
*
|
2001-03-19 |
2010-10-05 |
President & Fellows Of Harvard College |
Directed evolution of proteins
|
CA2442092A1
(fr)
*
|
2001-03-26 |
2002-10-17 |
Ribozyme Pharmaceuticals, Inc. |
Inhibition regulee par des oligonucleotides de la replication du virus de l'hepatite b et du virus de l'hepatite c
|
US7563255B2
(en)
|
2001-05-03 |
2009-07-21 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
DE10122847A1
(de)
*
|
2001-05-11 |
2002-11-21 |
Noxxon Pharma Ag |
Enterotoxin B bindende Nukleinsäure
|
US20050080031A1
(en)
*
|
2001-05-18 |
2005-04-14 |
Sirna Therapeutics, Inc. |
Nucleic acid treatment of diseases or conditions related to levels of Ras, HER2 and HIV
|
US20040006035A1
(en)
*
|
2001-05-29 |
2004-01-08 |
Dennis Macejak |
Nucleic acid mediated disruption of HIV fusogenic peptide interactions
|
US20040198682A1
(en)
*
|
2001-11-30 |
2004-10-07 |
Mcswiggen James |
RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA)
|
ES2474192T3
(es)
*
|
2001-05-25 |
2014-07-08 |
Duke University |
Moduladores de agentes farmacol�gicos
|
EP1390472A4
(fr)
*
|
2001-05-29 |
2004-11-17 |
Sirna Therapeutics Inc |
Traitement a l'acide nucleique de maladies ou d'affections associees aux taux de ras, her2 et hiv
|
KR20030033007A
(ko)
|
2001-05-31 |
2003-04-26 |
코울터 파머수티컬, 인코포레이티드 |
세포독소, 약물전구체, 링커 및 이에 유용한 안정화제
|
AU2775402A
(en)
*
|
2001-06-29 |
2003-01-02 |
Medimolecular Pty Ltd |
Nucleic acid ligands to complex targets
|
US8030465B2
(en)
|
2001-06-29 |
2011-10-04 |
Medimolecular Pty Ltd |
Nucleic acid ligands to complex targets
|
JP2005500058A
(ja)
|
2001-08-17 |
2005-01-06 |
ネオーズ テクノロジーズ, インコーポレイテッド |
シアリル化したオリゴサッカリドの化学的酵素的合成
|
US8834900B2
(en)
|
2001-08-17 |
2014-09-16 |
University Of Iowa Research Foundation |
Combination motif immune stimulatory oligonucleotides with improved activity
|
WO2003029492A1
(fr)
*
|
2001-09-28 |
2003-04-10 |
Justin Gallivan |
Genes metaboliques et procedes et compositions associes
|
FI115343B
(fi)
*
|
2001-10-22 |
2005-04-15 |
Filtronic Lk Oy |
Sisäinen monikaista-antenni
|
ES2346640T4
(es)
|
2001-10-26 |
2011-04-26 |
Noxxon Pharma Ag |
Ácido l-nucleico modificado.
|
US20030162190A1
(en)
*
|
2001-11-15 |
2003-08-28 |
Gorenstein David G. |
Phosphoromonothioate and phosphorodithioate oligonucleotide aptamer chip for functional proteomics
|
ATE414767T1
(de)
|
2001-11-22 |
2008-12-15 |
Sloning Biotechnology Gmbh |
Nukleinsäure-linker und deren verwendung in der gensynthese
|
AU2002357240A1
(en)
*
|
2001-12-14 |
2003-06-30 |
Yale University |
Nucleic acid diagnostic reagents and methods for detecting nucleic acids, polynucleotides and oligonucleotides
|
AU2002359761A1
(en)
|
2001-12-18 |
2003-06-30 |
Invenux, Inc. |
Antibiotic compounds
|
US20040002083A1
(en)
*
|
2002-01-29 |
2004-01-01 |
Ye Ding |
Statistical algorithms for folding and target accessibility prediction and design of nucleic acids
|
US7781396B2
(en)
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
AU2003215240A1
(en)
*
|
2002-02-14 |
2003-09-04 |
Illumina, Inc. |
Automated information processing in randomly ordered arrays
|
WO2003070740A1
(fr)
*
|
2002-02-15 |
2003-08-28 |
The Research Foundation Of State University Of New York |
Ribozymes a large activite d'aminoacylation de l'arn de transfert
|
EP1481090A4
(fr)
*
|
2002-02-15 |
2006-08-09 |
Somalogic Inc |
Methodes et reactifs destines a la detection d'une liaison de cibles par des ligands d'acides nucleiques
|
JP2005517718A
(ja)
*
|
2002-02-19 |
2005-06-16 |
シンセリカ・コーポレイション |
免疫応答および輸送の代替抗体による調整のための組成物および方法
|
WO2003106476A1
(fr)
*
|
2002-02-20 |
2003-12-24 |
Sirna Therapeutics, Inc |
Inhibition d'une infection a enterocoques et de l'activite de la cytolysine induite par des acides nucleiques
|
US8877901B2
(en)
|
2002-12-13 |
2014-11-04 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
US7591994B2
(en)
|
2002-12-13 |
2009-09-22 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
US20040023415A1
(en)
|
2002-03-05 |
2004-02-05 |
Konstantin Sokolov |
Biospecific contrast agents
|
US20030219801A1
(en)
*
|
2002-03-06 |
2003-11-27 |
Affymetrix, Inc. |
Aptamer base technique for ligand identification
|
US20040018515A1
(en)
*
|
2002-04-03 |
2004-01-29 |
Diener John L. |
Compositions selective for adenosine diphosphate and methods of using same
|
WO2003093504A1
(fr)
*
|
2002-05-06 |
2003-11-13 |
Noxxon Pharma Ag |
Procede d'amplification d'acides nucleiques
|
CN1655827B
(zh)
|
2002-05-27 |
2010-06-23 |
佩尔·松内·霍尔姆 |
腺病毒和编码其的核酸的新应用
|
WO2003102212A2
(fr)
*
|
2002-05-31 |
2003-12-11 |
Regents Of The University Of Minnesota |
Evolution in vitro d'arn et d'adn fonctionnels utilisant la selection electrophoretique
|
US20040249130A1
(en)
*
|
2002-06-18 |
2004-12-09 |
Martin Stanton |
Aptamer-toxin molecules and methods for using same
|
AU2003247576A1
(en)
*
|
2002-06-18 |
2003-12-31 |
Archemix Corp. |
Aptamer-toxin molecules and methods for using same
|
US7767803B2
(en)
|
2002-06-18 |
2010-08-03 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
US7655790B2
(en)
*
|
2002-07-12 |
2010-02-02 |
Sirna Therapeutics, Inc. |
Deprotection and purification of oligonucleotides and their derivatives
|
US6989442B2
(en)
*
|
2002-07-12 |
2006-01-24 |
Sirna Therapeutics, Inc. |
Deprotection and purification of oligonucleotides and their derivatives
|
US20040110235A1
(en)
*
|
2002-07-25 |
2004-06-10 |
David Epstein |
Regulated aptamer therapeutics
|
US7750140B2
(en)
*
|
2002-08-01 |
2010-07-06 |
Noxxon Pharma Ag |
Ghrelin binding nucleic acids
|
EP1393742A1
(fr)
|
2002-08-14 |
2004-03-03 |
atugen AG |
Utilisation de la protéine kinase N bêta
|
IL166718A0
(en)
|
2002-08-14 |
2006-01-15 |
Atugen Ag |
Further use of protein kinase n beta
|
US7785799B2
(en)
*
|
2002-08-16 |
2010-08-31 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods related to flavivirus envelope protein domain III antigens
|
DE10241938A1
(de)
*
|
2002-09-10 |
2004-03-25 |
Noxxon Pharma Ag |
Verfahren zur Selektion von Nukleinsäureliganden
|
WO2004025298A1
(fr)
|
2002-09-11 |
2004-03-25 |
University Of Florida |
Procedes d'analyse de lesions de cellules nerveuses
|
US9303262B2
(en)
|
2002-09-17 |
2016-04-05 |
Archemix Llc |
Methods for identifying aptamer regulators
|
EP2322535A3
(fr)
*
|
2002-09-20 |
2011-09-28 |
Yale University |
Riboswitchs, procedes d'utilisation et compositions a utiliser avec des riboswitchs
|
AU2003279089A1
(en)
*
|
2002-09-30 |
2004-04-19 |
Parallele Bioscience, Inc. |
Polynucleotide synthesis and labeling by kinetic sampling ligation
|
AU2003274011B2
(en)
|
2002-10-15 |
2010-03-04 |
Intercell Ag |
Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof
|
WO2005003291A2
(fr)
*
|
2002-10-16 |
2005-01-13 |
Board Of Regents Of The University Of Texas System |
Banques combinatoires d'aptameres a groupes phosphorothioate et phosphorodithioate oligonucleotidiques lies a des billes
|
US20060240022A1
(en)
|
2002-10-18 |
2006-10-26 |
Atugen Ag |
Factor involved in metastasis and uses thereof
|
GB0225833D0
(en)
*
|
2002-11-06 |
2002-12-11 |
Univ Leeds |
Nucleic acid ligands and uses therefor
|
US10100316B2
(en)
|
2002-11-21 |
2018-10-16 |
Archemix Llc |
Aptamers comprising CPG motifs
|
EP1581548A4
(fr)
*
|
2002-11-21 |
2008-04-23 |
Archemix Corp |
Agents thérapeutiques aptameres multivalents possédant des propriétés pharmacodynamiques ameliorées et des procédés de préparation et d'utilisation de ceux-ci
|
US20050124565A1
(en)
*
|
2002-11-21 |
2005-06-09 |
Diener John L. |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
US8039443B2
(en)
|
2002-11-21 |
2011-10-18 |
Archemix Corporation |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
US20040197802A1
(en)
|
2002-11-21 |
2004-10-07 |
Dahl Gary A. |
Methods for using primers that encode one strand of a double-stranded promoter
|
US8853376B2
(en)
|
2002-11-21 |
2014-10-07 |
Archemix Llc |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
JP2006514932A
(ja)
*
|
2002-11-25 |
2006-05-18 |
ジェネンコー・インターナショナル・インク |
皮膚、または髪に結合するペプチド
|
US20050037394A1
(en)
*
|
2002-12-03 |
2005-02-17 |
Keefe Anthony D. |
Method for in vitro selection of 2'-substituted nucleic acids
|
US7491699B2
(en)
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
WO2004053104A2
(fr)
|
2002-12-11 |
2004-06-24 |
Coley Pharmaceutical Group, Inc. |
Acides nucleiques 5'cpg et leurs methodes d'utilisation
|
US6936496B2
(en)
|
2002-12-20 |
2005-08-30 |
Hewlett-Packard Development Company, L.P. |
Nanowire filament
|
EP2058275A1
(fr)
|
2003-01-07 |
2009-05-13 |
Ramot at Tel-Aviv University Ltd. |
Nanostructures de peptides encapsulant un matériau étranger et leur procédé de fabrication
|
US6943768B2
(en)
|
2003-02-21 |
2005-09-13 |
Xtellus Inc. |
Thermal control system for liquid crystal cell
|
DE602004028445D1
(de)
*
|
2003-02-24 |
2010-09-16 |
Pritest Inc |
Lichtdurchlässige festmatrix-prüfvorrichtung zur mikroarray-analyse
|
US6861251B2
(en)
|
2003-02-24 |
2005-03-01 |
Pritest, Inc. |
Translucent solid matrix assay device for microarray analysis
|
JP2006520202A
(ja)
|
2003-03-04 |
2006-09-07 |
インターツェル・アクチェンゲゼルシャフト |
ストレプトコッカス・ピオゲネス抗原
|
US7140685B2
(en)
*
|
2003-03-11 |
2006-11-28 |
Gardner Kenneth J |
Swivel chair joint
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
CA2520868A1
(fr)
|
2003-03-31 |
2004-10-14 |
Intercell Ag |
Antigenes s. epidermidis
|
EP1608780B1
(fr)
*
|
2003-03-31 |
2011-08-24 |
McMASTER UNIVERSITY |
Methode de selection d'aptameres
|
EP2314719A1
(fr)
|
2003-04-15 |
2011-04-27 |
Intercell AG |
S. pneumoniae antigènes
|
EP1620547B1
(fr)
|
2003-04-21 |
2014-06-18 |
Archemix LLC |
Aptameres stabilises lies a un facteur de croissance derive de plaquette et leur utilisation en tant qu'agents therapeutiques d'oncologie
|
US20050250106A1
(en)
*
|
2003-04-24 |
2005-11-10 |
David Epstein |
Gene knock-down by intracellular expression of aptamers
|
WO2004099411A1
(fr)
*
|
2003-05-07 |
2004-11-18 |
Novartis Ag |
Procede pour analyser la dependance d'interactions arn/ligands vis-a-vis de la structure secondaire de l'arn
|
AU2004235952A1
(en)
|
2003-05-07 |
2004-11-18 |
Intercell Ag |
Streptococcus agalactiae antigens I + II
|
US8017755B2
(en)
|
2003-05-23 |
2011-09-13 |
President And Fellows Of Harvard College |
RNA-based transcriptional regulators
|
US7910523B2
(en)
*
|
2003-05-23 |
2011-03-22 |
Board Of Regents, The University Of Texas System |
Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting AP-1 transcription factors
|
US20060121489A1
(en)
*
|
2003-05-23 |
2006-06-08 |
Board Of Regents, The University Of Texas System |
High throughput screening of aptamer libraries for specific binding to proteins on viruses and other pathogens
|
DE10325152B4
(de)
*
|
2003-05-30 |
2011-07-21 |
Kage, Andreas, Dr., 12207 |
Verfahren zur quantitativen Bestimmung einer unbekannten Menge einer Zielmolekülspezies
|
EP2327720A1
(fr)
|
2003-05-30 |
2011-06-01 |
Intercell AG |
Antigènes d'entérocoque
|
US20050250094A1
(en)
*
|
2003-05-30 |
2005-11-10 |
Nanosphere, Inc. |
Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes
|
CN1279056C
(zh)
*
|
2003-06-06 |
2006-10-11 |
马菁 |
肿瘤相关抗原sm5-1的特异性抗体及其应用
|
US20050232926A1
(en)
*
|
2003-06-06 |
2005-10-20 |
Oncomax Acquisition Corp. |
Antibodies specific for cancer associated antigen SM5-1 and uses thereof
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
EP1493810A1
(fr)
|
2003-06-30 |
2005-01-05 |
Gentium S.p.A. |
Aptamères pour la cathepsine G basés sur de l'ADN
|
CA2532094A1
(fr)
|
2003-07-10 |
2005-05-06 |
Michigan State University |
Therapies et agents therapeutiques anticancereux cibles sur les facteurs sp1 et sp3
|
CA2533691A1
(fr)
*
|
2003-07-24 |
2005-02-03 |
Board Of Regents The University Of Texas System |
Thioaptameres permettant de decouvrir des voies physiologiques et de nouvelles strategies therapeutiques
|
EP2311994A1
(fr)
|
2003-08-01 |
2011-04-20 |
Life Technologies Corporation |
Compositions et procédés de préparation de courtes molécules d'ARN et d'autres acides nucléiques
|
US20050043245A1
(en)
*
|
2003-08-11 |
2005-02-24 |
Siler -Khodr Theresa M. |
Non-mammalian GnRH analogs and uses thereof in the immune system
|
CA2535799A1
(fr)
|
2003-08-15 |
2005-03-03 |
University Of Florida |
Identification de polynucleotides responsables de la virulence de porphyromonas gingivalis dans le diagnostic, le traitement, et la surveillance de maladies parodontales
|
EP2281885A1
(fr)
*
|
2003-08-27 |
2011-02-09 |
Ophthotech Corporation |
Combination thérapeutique pour le traitement des troubles oculaires néovasculaires
|
WO2005024042A2
(fr)
|
2003-09-04 |
2005-03-17 |
The Regents Of The University Of California |
Aptameres et procedes pour leur selection in vitro, et utilisations correspondantes
|
US20050064435A1
(en)
*
|
2003-09-24 |
2005-03-24 |
Xing Su |
Programmable molecular barcodes
|
CA2540407A1
(fr)
*
|
2003-09-25 |
2005-03-31 |
Tel Aviv University Future Technology Development L.P. |
Compositions et methodes d'utilisation de ces compositions pour le traitement des maladies associees a la substance amyloide
|
WO2005030989A1
(fr)
*
|
2003-09-30 |
2005-04-07 |
The Hospital For Sick Children |
Procede de detection in situ de proteines utilisant des aptameres
|
US7803624B2
(en)
|
2003-09-30 |
2010-09-28 |
Cytyc Corporation |
Automated cytological sample classification
|
US7625707B2
(en)
*
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
US7132298B2
(en)
*
|
2003-10-07 |
2006-11-07 |
Hewlett-Packard Development Company, L.P. |
Fabrication of nano-object array
|
US7223611B2
(en)
*
|
2003-10-07 |
2007-05-29 |
Hewlett-Packard Development Company, L.P. |
Fabrication of nanowires
|
KR20060125743A
(ko)
*
|
2003-11-10 |
2006-12-06 |
녹손 파르마 아게 |
생체 활성형 그렐린에 특이적으로 결합하는 핵산
|
WO2005051430A1
(fr)
|
2003-11-14 |
2005-06-09 |
Per Sonne Holm |
Nouvelle utilisation d'adenovirus et d'acides nucleiques les codant
|
WO2005051174A2
(fr)
*
|
2003-11-21 |
2005-06-09 |
The Trustees Of Columbia University In The City Of New York |
Compositions a base d'aptameres d'acides nucleiques et procedes
|
US20050123932A1
(en)
*
|
2003-12-09 |
2005-06-09 |
Mekbib Astatke |
Nucleic acid-chelating agent conjugates
|
GB0328448D0
(en)
*
|
2003-12-09 |
2004-01-14 |
Univ Leeds |
Agents for the regulation of transcription via zinc finger proteins
|
JP2007525661A
(ja)
*
|
2003-12-12 |
2007-09-06 |
セントルイス ユニバーシティー |
大分子その他の分析物の検出用生物センサー
|
US20080076119A9
(en)
*
|
2003-12-29 |
2008-03-27 |
Lei Sun |
Composite organic inorganic nanoclusters
|
US20050191665A1
(en)
*
|
2003-12-29 |
2005-09-01 |
Xing Su |
Composite organic-inorganic nanoclusters
|
US20050147963A1
(en)
*
|
2003-12-29 |
2005-07-07 |
Intel Corporation |
Composite organic-inorganic nanoparticles and methods for use thereof
|
US7361410B2
(en)
*
|
2003-12-29 |
2008-04-22 |
Intel Corporation |
External modification of composite organic inorganic nanoclusters comprising raman active organic compound
|
US7803931B2
(en)
|
2004-02-12 |
2010-09-28 |
Archemix Corp. |
Aptamer therapeutics useful in the treatment of complement-related disorders
|
DK2860251T3
(en)
|
2004-02-12 |
2018-06-06 |
Archemix Llc |
APTAPMER PHARMACEUTICALS USEFUL IN TREATMENT OF COMPLEMENT-RELATED DISEASES
|
US8389710B2
(en)
|
2004-02-27 |
2013-03-05 |
Operational Technologies Corporation |
Therapeutic nucleic acid-3′-conjugates
|
US8318920B2
(en)
*
|
2004-02-27 |
2012-11-27 |
Operational Technologies Corporation |
Therapeutic nucleic acid-3′-conjugates
|
US7910297B2
(en)
*
|
2004-02-27 |
2011-03-22 |
Operational Technologies Corporation |
Therapeutic nucleic acid-3' -conjugates
|
US20070066550A1
(en)
*
|
2004-03-05 |
2007-03-22 |
Diener John L |
Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics
|
US20060193821A1
(en)
*
|
2004-03-05 |
2006-08-31 |
Diener John L |
Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics
|
JP2007530586A
(ja)
|
2004-03-25 |
2007-11-01 |
ザ ファインスタイン インスティテュート フォー メディカル リサーチ |
神経性止血法
|
US10912712B2
(en)
|
2004-03-25 |
2021-02-09 |
The Feinstein Institutes For Medical Research |
Treatment of bleeding by non-invasive stimulation
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
US7407738B2
(en)
*
|
2004-04-02 |
2008-08-05 |
Pavel Kornilovich |
Fabrication and use of superlattice
|
US7794713B2
(en)
|
2004-04-07 |
2010-09-14 |
Lpath, Inc. |
Compositions and methods for the treatment and prevention of hyperproliferative diseases
|
JP2008505853A
(ja)
|
2004-04-13 |
2008-02-28 |
クインテセンス バイオサイエンシーズ インコーポレーティッド |
細胞傷害性薬剤としての非天然のリボヌクレアーゼ複合体
|
US20080214489A1
(en)
*
|
2004-04-19 |
2008-09-04 |
Anthony Dominic Keefe |
Aptamer-mediated intracellular delivery of oligonucleotides
|
US20050239134A1
(en)
*
|
2004-04-21 |
2005-10-27 |
Board Of Regents, The University Of Texas System |
Combinatorial selection of phosphorothioate single-stranded DNA aptamers for TGF-beta-1 protein
|
CN103045601B
(zh)
*
|
2004-04-22 |
2015-04-01 |
雷加多生物科学公司 |
改良的凝血因子调节物
|
US7579450B2
(en)
*
|
2004-04-26 |
2009-08-25 |
Archemix Corp. |
Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics
|
US7247531B2
(en)
|
2004-04-30 |
2007-07-24 |
Hewlett-Packard Development Company, L.P. |
Field-effect-transistor multiplexing/demultiplexing architectures and methods of forming the same
|
DE102004021707A1
(de)
*
|
2004-04-30 |
2005-11-24 |
Cytotools Gmbh |
Verfahren zur Isolierung von spezifischen Molekülen, die hochselektiv an ausgewählte Zielmoleküle binden
|
US7683435B2
(en)
|
2004-04-30 |
2010-03-23 |
Hewlett-Packard Development Company, L.P. |
Misalignment-tolerant multiplexing/demultiplexing architectures
|
US20060024814A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Peters Kevin F |
Aptamer-functionalized electrochemical sensors and methods of fabricating and using the same
|
US8568637B2
(en)
|
2004-08-02 |
2013-10-29 |
Ramot At Tel-Aviv University Ltd. |
Method of forming a fiber made of peptide nanostructures
|
US20070048797A1
(en)
*
|
2004-08-11 |
2007-03-01 |
Xing Su |
Composite organic inorganic nanoclusters as carriers and identifiers of tester molecules
|
EP1793816B1
(fr)
|
2004-08-19 |
2012-01-04 |
Tel Aviv University Future Technology Development L.P. |
Compositions pour le traitement de maladies associées à l'amyloide
|
US20060040258A1
(en)
*
|
2004-08-23 |
2006-02-23 |
Huiyan Guo |
Water-soluble conjugates and methods of preparation
|
EP1796537A4
(fr)
*
|
2004-08-25 |
2012-03-07 |
Univ Michigan |
Compositions a base de dendrimeres et procedes d'utilisation de celles-ci
|
US7776547B2
(en)
*
|
2004-08-26 |
2010-08-17 |
Intel Corporation |
Cellular analysis using Raman surface scanning
|
US20060046311A1
(en)
*
|
2004-08-26 |
2006-03-02 |
Intel Corporation |
Biomolecule analysis using Raman surface scanning
|
WO2006029258A2
(fr)
|
2004-09-07 |
2006-03-16 |
Archemix Corp. |
Chimie medicale utilisant des aptameres
|
CA2579374A1
(fr)
*
|
2004-09-07 |
2006-03-30 |
Archemix Corp. |
Aptameres au facteur de von willebrand et leur utilisation en tant qu'agents therapeutiques pour des maladies thrombotiques
|
US7566701B2
(en)
|
2004-09-07 |
2009-07-28 |
Archemix Corp. |
Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
|
US7786086B2
(en)
*
|
2004-09-08 |
2010-08-31 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
|
US7659091B2
(en)
|
2004-09-21 |
2010-02-09 |
Nourheart, Inc. |
Diagnostic marker
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
MY159370A
(en)
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
WO2006050002A2
(fr)
*
|
2004-10-28 |
2006-05-11 |
Idexx Laboratories, Inc. |
Compositions destinees a l'administration controlee de composes pharmaceutiquement actifs
|
EP1807107B1
(fr)
|
2004-11-02 |
2011-09-07 |
Archemix Corp. |
Aptameres stabilises se fixant au pdgf, et leur utilisation a des fins de therapie oncologique
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
ATE489132T1
(de)
|
2004-12-27 |
2010-12-15 |
The Feinstein Inst Medical Res |
Behandlung von entzündlichen erkrankungen durch elektrische stimulation des vagus-nervs
|
US11207518B2
(en)
|
2004-12-27 |
2021-12-28 |
The Feinstein Institutes For Medical Research |
Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
|
KR101366482B1
(ko)
|
2004-12-27 |
2014-02-21 |
사일런스 테라퓨틱스 아게 |
코팅된 지질 복합체 및 이들의 용도
|
US20060147941A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Intel Corporation |
Methods and apparatus for SERS assay of biological analytes
|
US9505846B2
(en)
*
|
2005-01-28 |
2016-11-29 |
Life Technologies Corporation |
Multi-component inhibitors of nucleic acid polymerases
|
US7375012B2
(en)
*
|
2005-02-28 |
2008-05-20 |
Pavel Kornilovich |
Method of forming multilayer film
|
US20100196509A1
(en)
|
2005-02-28 |
2010-08-05 |
Jonathan Braun |
Methods for Diagnosis and Treatment of Endometrial Cancer
|
WO2006096754A2
(fr)
*
|
2005-03-07 |
2006-09-14 |
Archemix Corp. |
Aptameres stabilises d'apsm et leur utilisation comme agents therapeutiques contre le cancer de la prostate
|
MX2007010922A
(es)
|
2005-03-10 |
2007-10-12 |
Genentech Inc |
Metodos y composiciones para modular la integridad vascular.
|
US20060205090A1
(en)
*
|
2005-03-14 |
2006-09-14 |
Newton Michael W |
Water-soluble conjugates for electrochemical detection
|
CA2602602A1
(fr)
*
|
2005-03-24 |
2006-09-28 |
Syracuse University |
Methode pour decouvrir des sequences oligonucleotidiques presentant une haute affinite et une haute specificite et sequences oligonucleotidiques derivees destinees a une reconnaissance de cible
|
US20100036106A1
(en)
*
|
2005-03-30 |
2010-02-11 |
Nec Soft, Ltd. |
High-Affinity RNA Aptamer Molecule Against Glutathione-S-Transferase Protein
|
UY29460A1
(es)
*
|
2005-04-08 |
2006-11-30 |
Noxxon Pharma Ag |
Acidos nucleicos de union a ghrelin
|
US8318906B2
(en)
|
2005-04-15 |
2012-11-27 |
The Regents Of The University Of California |
EMP2 antibodies and their therapeutic uses
|
DE102005022057B3
(de)
*
|
2005-05-09 |
2007-02-08 |
Analyticon Biotechnologies Ag |
Verfahren zur Herstellung von Liganden, Liganden und Test-Kit
|
US20060281702A1
(en)
*
|
2005-05-18 |
2006-12-14 |
Board Of Regents, The University Of Texas System |
Combinatorial selection of phosphorothioate aptamers for RNases
|
US8956857B2
(en)
|
2005-06-06 |
2015-02-17 |
Mediomics, Llc |
Three-component biosensors for detecting macromolecules and other analytes
|
US7795009B2
(en)
*
|
2005-06-15 |
2010-09-14 |
Saint Louis University |
Three-component biosensors for detecting macromolecules and other analytes
|
WO2006135527A2
(fr)
|
2005-06-10 |
2006-12-21 |
Saint Louis University |
Procedes de selection d'aptameres
|
US7811809B2
(en)
*
|
2005-06-15 |
2010-10-12 |
Saint Louis University |
Molecular biosensors for use in competition assays
|
EP1904846A4
(fr)
*
|
2005-06-29 |
2009-03-18 |
Rules Based Medicine Inc |
Méthodes et trousses pour le diagnostic du syndrome coronaire aigu
|
US8101385B2
(en)
|
2005-06-30 |
2012-01-24 |
Archemix Corp. |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
KR20080025181A
(ko)
|
2005-06-30 |
2008-03-19 |
아케믹스 코포레이션 |
완전 2'-변형된 핵산 전사체를 생성하기 위한 물질 및 방법
|
EP1918372A4
(fr)
|
2005-07-05 |
2009-08-12 |
Ribomic Inc |
Acide nucléique capable de se lier à une immunoglobuline g et son utilisation
|
US7662571B2
(en)
|
2005-07-14 |
2010-02-16 |
Nourheart Inc. |
Mitochondrial markers of ischemia
|
US20100254901A1
(en)
*
|
2005-07-28 |
2010-10-07 |
Smith Cassandra L |
Compositions comprising nucleic acid aptamers
|
US20070041934A1
(en)
*
|
2005-08-12 |
2007-02-22 |
Regents Of The University Of Michigan |
Dendrimer based compositions and methods of using the same
|
BRPI0617546A2
(pt)
|
2005-09-26 |
2011-07-26 |
Medarex Inc |
conjugado de fÁrmaco-anticorpo, formulaÇço farmacÊutica, mÉtodo para matar uma cÉlula de tumor, mÉtodo para retardar ou interromper o crescimento de um tumor em um sujeito mamÍfero e composto
|
US10004828B2
(en)
|
2005-10-11 |
2018-06-26 |
Romat at Tel-Aviv University Ltd. |
Self-assembled Fmoc-ff hydrogels
|
GB0521139D0
(en)
|
2005-10-18 |
2005-11-23 |
Univ Sheffield |
Therapeutic agent
|
WO2007056223A2
(fr)
*
|
2005-11-03 |
2007-05-18 |
Lohocla Research Corporation |
Tests de diagnostic des troubles de la consommation de substances
|
US7879212B2
(en)
*
|
2005-11-03 |
2011-02-01 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructure-coated electrodes
|
NZ568705A
(en)
|
2005-11-04 |
2012-07-27 |
Biogen Idec Inc |
Methods for promoting neurite outgrowth and survival of dopaminergic neurons
|
US8017159B2
(en)
*
|
2005-11-16 |
2011-09-13 |
Idexx Laboratories, Inc. |
Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same
|
US7754679B2
(en)
*
|
2005-11-16 |
2010-07-13 |
Idexx Laboratories, Inc. |
Pharmaceutical compositions for the administration of aptamers
|
US8114440B2
(en)
*
|
2005-11-16 |
2012-02-14 |
Idexx Laboratories Inc. |
Pharmaceutical compositions for the administration of aptamers
|
JP5119444B2
(ja)
*
|
2005-12-06 |
2013-01-16 |
国立大学法人 東京大学 |
多目的アシル化触媒とその用途
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
EP2674440B1
(fr)
|
2005-12-16 |
2019-07-03 |
IBC Pharmaceuticals, Inc. |
Ensembles bioactifs à base d'immunoglobuline multivalent
|
US20070155022A1
(en)
*
|
2005-12-30 |
2007-07-05 |
Mineo Yamakawa |
Degenerate binding detection and protein identification using Raman spectroscopy nanoparticle labels
|
US20100061932A1
(en)
|
2005-12-30 |
2010-03-11 |
Evonik Roehm Gmbh |
Peptides useful as cell-penetrating peptides
|
US20070239483A1
(en)
*
|
2006-01-09 |
2007-10-11 |
Biophysical Corporation |
Methods for individualized health assessment service
|
JP2009536313A
(ja)
|
2006-01-11 |
2009-10-08 |
レインダンス テクノロジーズ, インコーポレイテッド |
ナノリアクターの形成および制御において使用するマイクロ流体デバイスおよび方法
|
EP1994171B1
(fr)
|
2006-01-17 |
2015-03-11 |
Somalogic, Inc. |
Analyses multiplexées d'échantillons test
|
US8669345B2
(en)
|
2006-01-27 |
2014-03-11 |
Biogen Idec Ma Inc. |
Nogo receptor antagonists
|
US7922000B2
(en)
*
|
2006-02-15 |
2011-04-12 |
Miraial Co., Ltd. |
Thin plate container with a stack of removable loading trays
|
US8460879B2
(en)
|
2006-02-21 |
2013-06-11 |
The Trustees Of Tufts College |
Methods and arrays for target analyte detection and determination of target analyte concentration in solution
|
CA3148917A1
(fr)
|
2006-03-08 |
2007-09-13 |
Archemix Llc |
Aptameres de liaison du complement et agents anti-c5 utiles dans le traitement de troubles oculaires
|
EP1996942A1
(fr)
*
|
2006-03-10 |
2008-12-03 |
Tethys Bioscience, Inc. |
Fractionnement multiplex de proteines
|
US20070231855A1
(en)
*
|
2006-03-28 |
2007-10-04 |
Fujitsu Limited |
Functional molecule and manufacturing method therefor
|
JP4984990B2
(ja)
*
|
2006-03-28 |
2012-07-25 |
富士通株式会社 |
機能性分子の製造方法
|
EP2007435B1
(fr)
|
2006-03-31 |
2019-12-18 |
Massachusetts Institute Of Technology |
Système pour l'administration ciblée d'agents thérapeutiques
|
CA2649630C
(fr)
|
2006-04-20 |
2016-04-05 |
Silence Therapeutics Ag |
Preparations de lipoplex pour administration specifique sur l'endothelium vasculaire
|
WO2007131171A1
(fr)
*
|
2006-05-05 |
2007-11-15 |
Rules-Based Medicine, Inc. |
Procédés et trousses destinés au diagnostic de l'hypothyroïdie
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
EP2530168B1
(fr)
|
2006-05-11 |
2015-09-16 |
Raindance Technologies, Inc. |
Dispositifs microfluidiques
|
DE202006007590U1
(de)
|
2006-05-12 |
2006-12-14 |
Osaka University |
Verwendung einer Zusammensetzung, die Sema7A- und VLA-1-Interaktion inhibiert, zum Behandeln von Cytokin-vermittelten Erkrankungen
|
CA2652280C
(fr)
|
2006-05-15 |
2014-01-28 |
Massachusetts Institute Of Technology |
Polymeres pour particules fonctionnelles
|
US7862812B2
(en)
|
2006-05-31 |
2011-01-04 |
Lpath, Inc. |
Methods for decreasing immune response and treating immune conditions
|
US20070292397A1
(en)
*
|
2006-06-19 |
2007-12-20 |
Mcnulty Amy K |
Method for the detection and neutralization of bacteria
|
EP2044097A4
(fr)
|
2006-06-23 |
2010-10-06 |
Quintessence Biosciences Inc |
Ribonucléases modifiées
|
WO2007150030A2
(fr)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Synthèse microfluidique de nanoparticules organiques
|
US20080008694A1
(en)
|
2006-07-05 |
2008-01-10 |
Elgebaly Salwa A |
Methods to prevent and treat diseases
|
US8298801B2
(en)
*
|
2006-07-17 |
2012-10-30 |
Quintessence Biosciences, Inc. |
Methods and compositions for the treatment of cancer
|
WO2008011157A2
(fr)
|
2006-07-20 |
2008-01-24 |
The General Hospital Corporation |
Procédés, compositions, et trousses permettant une activation sélective de protoxines par un ciblage combinatoire
|
US7645582B2
(en)
*
|
2006-07-21 |
2010-01-12 |
Hitachi Chemical Co., Ltd. |
Aptamers that bind to listeria surface proteins
|
WO2008011608A2
(fr)
*
|
2006-07-21 |
2008-01-24 |
Hitachi Chemical Co., Ltd. |
Ligands d'acide nucléique aptes à se lier à l'internaline b ou l'internaline a
|
WO2008009477A2
(fr)
|
2006-07-21 |
2008-01-24 |
Silence Therapeutics Ag |
Moyen destiné à inhiber l'expression de la protéine kinase 3
|
US20080031903A1
(en)
*
|
2006-07-27 |
2008-02-07 |
Andrea Gambotto |
Method of treating ocular infections
|
EP3159417B1
(fr)
*
|
2006-08-01 |
2021-10-06 |
Gen-Probe Incorporated |
Procédés de capture de cible non spécifique d'acides nucléiques
|
WO2008015884A1
(fr)
|
2006-08-03 |
2008-02-07 |
Nec Soft, Ltd. |
Procédé de préparation d'un oligonucléotide
|
WO2008021123A1
(fr)
|
2006-08-07 |
2008-02-21 |
President And Fellows Of Harvard College |
Tensioactifs fluorocarbonés stabilisateurs d'émulsions
|
US20080070802A1
(en)
*
|
2006-08-23 |
2008-03-20 |
Moerschell Richard P |
Directed heterobifunctional linkers
|
WO2008031133A2
(fr)
|
2006-09-15 |
2008-03-20 |
Intercell Ag |
Antigènes de borrelia
|
WO2008045952A2
(fr)
*
|
2006-10-10 |
2008-04-17 |
The Regents Of The University Of Michigan |
Cellules précurseur de photorécepteur
|
JP4841396B2
(ja)
|
2006-10-18 |
2011-12-21 |
Necソフト株式会社 |
塩基配列の同定装置、核酸分子の二次構造取得装置、塩基配列の同定方法、核酸分子の二次構造取得方法、プログラム及び記録媒体
|
EP1913955A1
(fr)
|
2006-10-19 |
2008-04-23 |
Gerhard, Markus |
Nouveau méthode pour le traitement des infections par H. pylori
|
WO2008064304A2
(fr)
*
|
2006-11-22 |
2008-05-29 |
Trana Discovery, Inc. |
Compositions et procédés pour l'identification d'inhibiteurs de la synthèse des protéines
|
KR20090097188A
(ko)
|
2006-12-19 |
2009-09-15 |
제넨테크, 인크. |
조기 종양의 치료 및 아주반트 및 네오아주반트 요법을 위한 vegh-특이적 길항제
|
WO2008089059A1
(fr)
*
|
2007-01-12 |
2008-07-24 |
Rules-Based Medicine, Inc. |
Procédés et kits pour le diagnostic de la galactosémie
|
US7964356B2
(en)
|
2007-01-16 |
2011-06-21 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
US8975026B2
(en)
|
2007-01-16 |
2015-03-10 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
US7855054B2
(en)
*
|
2007-01-16 |
2010-12-21 |
Somalogic, Inc. |
Multiplexed analyses of test samples
|
US20110136099A1
(en)
*
|
2007-01-16 |
2011-06-09 |
Somalogic, Inc. |
Multiplexed Analyses of Test Samples
|
US7947447B2
(en)
|
2007-01-16 |
2011-05-24 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
US8586303B1
(en)
|
2007-01-22 |
2013-11-19 |
Steven Albert Benner |
In vitro selection with expanded genetic alphabets
|
US9725713B1
(en)
|
2007-01-22 |
2017-08-08 |
Steven A Benner |
In vitro selection with expanded genetic alphabets
|
WO2008092041A2
(fr)
|
2007-01-24 |
2008-07-31 |
Carnegie Mellon University |
Biocapteurs optiques
|
US8772046B2
(en)
|
2007-02-06 |
2014-07-08 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
WO2008098165A2
(fr)
|
2007-02-09 |
2008-08-14 |
Massachusetts Institute Of Technology |
Bioréacteur oscillant pour la culture de cellules
|
WO2008100791A1
(fr)
*
|
2007-02-16 |
2008-08-21 |
Rules-Based Medicine, Inc. |
Procédés et kits pour le diagnostic d'une drépanocytose
|
DE102007011702A1
(de)
|
2007-03-08 |
2008-09-11 |
Rheinische Friedrich-Wilhelms Universität |
Aptamer-basierte Reagenzien
|
WO2008109797A1
(fr)
*
|
2007-03-08 |
2008-09-12 |
Rules-Based Medicine, Inc. |
Procédés pour le dépistage rapide d'une pathologie
|
WO2008124634A1
(fr)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Micelles inverses encapsulées par un polymère
|
ATE501280T1
(de)
*
|
2007-04-04 |
2011-03-15 |
Chimera Biotec Gmbh |
Verfahren zum nachweis eines analyten in einer biologischen matrix
|
WO2008124632A1
(fr)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Nanoparticules assistées par des composés amphiphiles pour délivrance ciblée
|
US20080248958A1
(en)
*
|
2007-04-05 |
2008-10-09 |
Hollenbach Andrew D |
System for pulling out regulatory elements in vitro
|
EP2137656A2
(fr)
*
|
2007-04-19 |
2009-12-30 |
The Regents of the University of Michigan |
Compositions à base de dendrimères et procédés pour les utiliser
|
WO2008130623A1
(fr)
|
2007-04-19 |
2008-10-30 |
Brandeis University |
Manipulation de fluides, composants fluidiques et réactions dans des systèmes microfluidiques
|
EP2145185A4
(fr)
|
2007-04-30 |
2010-06-02 |
Nanogen Inc |
Dosage de plusieurs analytes
|
EP2497779A1
(fr)
|
2007-05-02 |
2012-09-12 |
Intercell AG |
Antigènes de Klebsiella
|
EP2511291A3
(fr)
|
2007-06-18 |
2012-11-07 |
Intercell AG |
Antigènes de Chlamydia
|
EP2336314A1
(fr)
|
2007-07-17 |
2011-06-22 |
Somalogic, Inc. |
Selex et photoselex améliorés
|
US8828960B2
(en)
*
|
2007-07-17 |
2014-09-09 |
Idexx Laboratories, Inc. |
Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
|
FR2920024B1
(fr)
|
2007-08-14 |
2012-12-14 |
Lfb Biotechnologies |
Procede de purification ou de detection d'une proteine cible
|
US9175015B2
(en)
|
2007-08-22 |
2015-11-03 |
Colorado School Of Mines |
Gold nanoparticle conjugates and uses thereof
|
WO2009029614A1
(fr)
|
2007-08-27 |
2009-03-05 |
The Feinstein Institute For Medical Research |
Dispositifs et procédés permettant d'inhiber l'activation de granulocytes par stimulation neurale
|
DE102007041476B4
(de)
|
2007-08-31 |
2017-03-30 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Aptamere, die an ein an der Hämostase beteiligtes Zielmolekül binden
|
WO2009032901A1
(fr)
*
|
2007-09-04 |
2009-03-12 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Biodétecteurs et procédés apparentés
|
WO2009033027A2
(fr)
|
2007-09-05 |
2009-03-12 |
Medtronic, Inc. |
Suppression de l'expression et/ou de la fonction du gène scn9a pour le traitement de la douleur
|
WO2009072001A2
(fr)
*
|
2007-09-12 |
2009-06-11 |
Aurelium Biopharma Inc. |
Diagnostics dirigés contre slc9a3r1 pour une maladie néoplasique
|
CA2699370A1
(fr)
*
|
2007-09-14 |
2009-03-19 |
Trana Discovery |
Compositions et procedes pour l'identification d'inhibiteurs d'une infection retrovirale
|
WO2009040665A2
(fr)
|
2007-09-24 |
2009-04-02 |
Performance Plants, Inc. |
Plantes ayant une biomasse accrue
|
EP2197454A4
(fr)
*
|
2007-09-25 |
2012-07-04 |
Idexx Lab Inc |
Compositions pharmaceutiques pour l'administration d'oligonucléotides
|
CA2934220C
(fr)
|
2007-10-02 |
2019-11-05 |
Theranos, Inc. |
Dispositifs modulaires a utiliser sur place et leurs utilisations
|
EP2045326A1
(fr)
*
|
2007-10-05 |
2009-04-08 |
Bayer CropScience AG |
Procédé d'identification du partenaire d'interaction d'un agent actif
|
US9200382B2
(en)
*
|
2007-10-05 |
2015-12-01 |
The Regents Of The University Of California |
High-stringency screening of target-binding partners using a microfluidic device
|
US9464135B2
(en)
|
2007-10-08 |
2016-10-11 |
The Regents Of The University Of California |
Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)
|
CA2702043A1
(fr)
*
|
2007-10-08 |
2009-04-16 |
Quintessence Biosciences, Inc. |
Compositions et procedes pour des therapies a base de ribonuclease
|
JP2011500569A
(ja)
|
2007-10-12 |
2011-01-06 |
マサチューセッツ インスティテュート オブ テクノロジー |
ワクチンナノテクノロジー
|
US20090163437A1
(en)
*
|
2007-10-16 |
2009-06-25 |
Regado Biosciences, Inc. |
Steady-state subcutaneous administration of aptamers
|
CN101835904A
(zh)
†
|
2007-10-22 |
2010-09-15 |
普罗诺塔股份有限公司 |
选择适配体的方法
|
US8906700B2
(en)
|
2007-11-06 |
2014-12-09 |
Ambergen, Inc. |
Methods and compositions for phototransfer
|
WO2009064424A1
(fr)
*
|
2007-11-13 |
2009-05-22 |
Rational Affinity Devices, L.L.C. |
Ligands à affinité accordable pour la séparation et la détection de substances cible
|
EP2268664B1
(fr)
|
2007-12-03 |
2017-05-24 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Compositions doc1 et méthodes de traitement du cancer
|
WO2009076323A2
(fr)
|
2007-12-06 |
2009-06-18 |
Genalyte Inc. |
Surveillance d'un procédé enzymatique
|
US8865401B2
(en)
|
2007-12-14 |
2014-10-21 |
The Johns Hopkins University |
Purification and concentration of proteins and DNA from a complex sample using isotachophoresis and a device to perform the purification
|
WO2009078939A1
(fr)
*
|
2007-12-17 |
2009-06-25 |
Brown University |
Procédés d'identification de ligands nucléotidiques
|
CA2711373C
(fr)
|
2008-01-07 |
2014-10-28 |
Luminex Corporation |
Isolement et enumeration de cellules a partir d'une matrice d'echantillon complexe
|
HUE031207T2
(hu)
|
2008-01-11 |
2017-07-28 |
Adheron Therapeutics Inc |
Cadherin-11 EC1 domén elleni antitestek gyulladásos ízületi rendellenességek kezeléséhez
|
US20090233295A1
(en)
*
|
2008-01-29 |
2009-09-17 |
Elias Georges |
Trim59 directed diagnostics for neoplastic disease
|
EP3115785A3
(fr)
|
2008-02-04 |
2017-02-22 |
Banyan Biomarkers, Inc. |
Procédé pour diagnostiquer ou traiter des lésions cérébrales
|
CA2718337A1
(fr)
*
|
2008-03-12 |
2009-12-17 |
Syracuse University |
Selection directe d'aptameres definis de maniere structurale
|
US8252834B2
(en)
|
2008-03-12 |
2012-08-28 |
The Regents Of The University Of Michigan |
Dendrimer conjugates
|
US20100048913A1
(en)
|
2008-03-14 |
2010-02-25 |
Angela Brodie |
Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
|
US9211409B2
(en)
|
2008-03-31 |
2015-12-15 |
The Feinstein Institute For Medical Research |
Methods and systems for reducing inflammation by neuromodulation of T-cell activity
|
US9115352B2
(en)
|
2008-03-31 |
2015-08-25 |
Sloning Biotechnology Gmbh |
Method for the preparation of a nucleic acid library
|
US9662490B2
(en)
|
2008-03-31 |
2017-05-30 |
The Feinstein Institute For Medical Research |
Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
|
MX364200B
(es)
|
2008-04-09 |
2019-04-16 |
Genentech Inc |
Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
|
JP2011521626A
(ja)
|
2008-05-02 |
2011-07-28 |
エピセンター テクノロジーズ コーポレーション |
Rnaポリホスファターゼの組成物、キットおよびそれらの使用
|
US20110229498A1
(en)
|
2008-05-08 |
2011-09-22 |
The Johns Hopkins University |
Compositions and methods for modulating an immune response
|
US20120003749A1
(en)
*
|
2008-05-21 |
2012-01-05 |
Nec Soft, Ltd. |
Nucleic acid molecule capable of binding to 2,4,6-trinitrophenyl skeleton, method for detecting compound having 2,4,6-trinitrophenyl skeleton using the nucleic acid molecule, and use of the nucleic acid molecule
|
US8323945B2
(en)
|
2008-06-06 |
2012-12-04 |
Danisco Us Inc. |
Variant alpha-amylases from Bacillus subtilis and methods of uses, thereof
|
US8722638B2
(en)
*
|
2008-06-20 |
2014-05-13 |
Children's Medical Center Corporation |
Methods for the modulation of angiogenesis
|
AU2009273052B2
(en)
|
2008-07-14 |
2015-09-17 |
The University Of Tokyo |
Aptamer against IL-17 and use thereof
|
WO2010007526A1
(fr)
|
2008-07-17 |
2010-01-21 |
Andreas Pfuetzner |
Biomarqueurs pour cardiodiabète
|
WO2010009438A1
(fr)
|
2008-07-17 |
2010-01-21 |
Andreas Pfuetzner |
Biomarqueurs pour l'insulinorésistance et le dysfonctionnement des bêta-cellules
|
US8703416B2
(en)
|
2008-07-17 |
2014-04-22 |
Somalogic, Inc. |
Method for purification and identification of sperm cells
|
WO2010009365A1
(fr)
|
2008-07-18 |
2010-01-21 |
Raindance Technologies, Inc. |
Bibliothèque de gouttelettes
|
EP4235181A3
(fr)
|
2008-08-11 |
2024-02-28 |
Banyan Biomarkers Inc |
Procédé de détection de biomarqueur et dosage d'état neurologique
|
US8968705B2
(en)
|
2008-08-22 |
2015-03-03 |
Colorado School Of Mines |
Gold/lanthanide nanoparticle conjugates and uses thereof
|
US20100068729A1
(en)
*
|
2008-09-12 |
2010-03-18 |
Rules-Based Medicine, Inc. |
Method and kits for the diagnosis of diabetes
|
EP2354225B1
(fr)
*
|
2008-09-24 |
2015-04-22 |
Ribomic Inc. |
Aptamère pour le ngf et ses utilisations
|
US20110229920A1
(en)
*
|
2008-09-29 |
2011-09-22 |
Trana Discovery, Inc. |
Screening methods for identifying specific staphylococcus aureus inhibitors
|
US8889635B2
(en)
|
2008-09-30 |
2014-11-18 |
The Regents Of The University Of Michigan |
Dendrimer conjugates
|
US8029782B2
(en)
|
2008-10-01 |
2011-10-04 |
Quintessence Biosciences, Inc. |
Therapeutic ribonucleases
|
AU2009302217A1
(en)
|
2008-10-09 |
2010-04-15 |
Northeastern University |
Multifunctional self-assembling polymeric nanosystems
|
WO2010042933A2
(fr)
|
2008-10-10 |
2010-04-15 |
Northwestern University |
Inhibition et traitement des métastases du cancer de la prostate
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US9101645B2
(en)
|
2008-10-22 |
2015-08-11 |
Genentech, Inc. |
Modulation of axon degeneration
|
EP2347247B1
(fr)
|
2008-10-27 |
2019-06-26 |
Genalyte, Inc. |
Biocapteurs basés sur des sondes et capteurs optiques
|
EP3971570A3
(fr)
|
2008-10-29 |
2022-11-09 |
BG Medicine, Inc. |
Immunodosage de galectine-3
|
EP2346904B1
(fr)
|
2008-10-29 |
2017-04-12 |
China Synthetic Rubber Corporation |
Méthodes et agents pour diagnostiquer et traiter un carcinome hépatocellulaire
|
WO2010054321A2
(fr)
|
2008-11-07 |
2010-05-14 |
The Regents Of The University Of Michigan |
Méthodes de traitement de troubles auto-immuns et/ou de troubles inflammatoires
|
AU2009316801C1
(en)
|
2008-11-18 |
2015-12-24 |
Setpoint Medical Corporation |
Devices and methods for optimizing electrode placement for anti-inflammatory stimulation
|
CA2744003C
(fr)
|
2008-11-21 |
2016-03-15 |
Mediomics Llc |
Biocapteur pour la detection de multiples epitopes sur une cible
|
AU2009323767A1
(en)
|
2008-12-04 |
2011-07-21 |
IKFE Instituit fur klinische Forschung und Entwicklung GmbH |
Biomarkers for atherosclerosis
|
WO2010067207A1
(fr)
|
2008-12-11 |
2010-06-17 |
Ikfe Gmbh |
Biomarqueurs pour réponse aux sensibilisateurs à l'insuline
|
CA2688174C
(fr)
|
2008-12-19 |
2018-08-07 |
F. Hoffmann-La Roche Ag |
Composition seche de reactifs comprenant de la polymerase stabilisee
|
US20100209350A1
(en)
|
2008-12-30 |
2010-08-19 |
Andreas Pfuetzner |
Biomarkers for Adipose Tissue Activity
|
EP2382475A2
(fr)
|
2009-01-07 |
2011-11-02 |
IKFE GmbH |
Marqueurs biologiques pour la régulation de l'appétit
|
AU2010210422A1
(en)
|
2009-02-05 |
2011-08-18 |
Tokai Pharmaceuticals, Inc. |
Novel prodrugs of steroidal CYP17 inhibitors/antiandrogens
|
PT3903829T
(pt)
|
2009-02-13 |
2023-06-02 |
Immunomedics Inc |
Imunoconjugados com uma ligação intracelular clivável
|
WO2010092176A2
(fr)
|
2009-02-13 |
2010-08-19 |
Intercell Ag |
Antigènes haemophilus influenzae non typables
|
US9249306B2
(en)
|
2009-02-18 |
2016-02-02 |
Carnegie Mellon University |
Quenched dendrimeric dyes for florescence detection
|
FR2942232B1
(fr)
|
2009-02-19 |
2015-03-13 |
Lfb Biotechnologies |
Moyens pour la purification d'une proteine de la coagulation et procedes pour sa mise en oeuvre
|
JP5980508B2
(ja)
|
2009-03-11 |
2016-08-31 |
プロメディオール, インコーポレイテッド |
自己免疫障害に対する処置方法
|
JP5797565B2
(ja)
|
2009-03-11 |
2015-10-21 |
プロメディオール, インコーポレイテッド |
過敏性障害(hypersensitive disorder)に対する処置および診断方法
|
EP3415235A1
(fr)
|
2009-03-23 |
2018-12-19 |
Raindance Technologies Inc. |
Manipulation de gouttelettes microfluidiques
|
JP5561755B2
(ja)
|
2009-04-01 |
2014-07-30 |
Necソリューションイノベータ株式会社 |
Selex法用のプライマーの設計方法、プライマーの製造方法、アプタマーの製造方法、プライマーの設計装置、プライマー設計用コンピュータプログラムおよび記録媒体
|
CA2758322C
(fr)
|
2009-04-10 |
2019-04-02 |
Tufts Medical Center, Inc. |
Activation de par-1 par la metalloproteinase-1 (mmp-1)
|
TWI578992B
(zh)
*
|
2009-04-30 |
2017-04-21 |
諾克森製藥股份有限公司 |
與鐵調節激素(hepcidin)結合之核酸類
|
US8886339B2
(en)
|
2009-06-09 |
2014-11-11 |
Setpoint Medical Corporation |
Nerve cuff with pocket for leadless stimulator
|
US9211410B2
(en)
|
2009-05-01 |
2015-12-15 |
Setpoint Medical Corporation |
Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
|
US8788034B2
(en)
|
2011-05-09 |
2014-07-22 |
Setpoint Medical Corporation |
Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
|
US8996116B2
(en)
|
2009-10-30 |
2015-03-31 |
Setpoint Medical Corporation |
Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
|
EP2427205A2
(fr)
|
2009-05-04 |
2012-03-14 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Agonistes du récepteur par2 utilisés dans le traitement ou la prévention des infections du virus de la grippe a
|
EP2430033A4
(fr)
*
|
2009-05-05 |
2012-11-07 |
Altermune Technologies Llc |
Immunité chimiquement programmable
|
US20100291706A1
(en)
|
2009-05-15 |
2010-11-18 |
Millipore Corporation |
Dye conjugates and methods of use
|
US9551650B2
(en)
|
2009-06-01 |
2017-01-24 |
Cornell University |
Integrated optofluidic system using microspheres
|
AU2010256511B2
(en)
|
2009-06-03 |
2016-01-14 |
Tobira Therapeutics, Inc. |
Nucleic acid modulators of glycoprotein VI
|
CA2764503A1
(fr)
|
2009-06-05 |
2010-12-09 |
University Of Florida Research Foundation, Inc. |
Isolement et suppression ciblee de genes de la biosynthese de lignine dans la canne a sucre
|
AR077049A1
(es)
|
2009-06-11 |
2011-07-27 |
Otsuka Pharma Co Ltd |
Aptamero contra quimasa y su uso
|
EP2997974B1
(fr)
|
2009-06-19 |
2018-06-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Procédé et composition pharmaceutique pour une utilisation dans le traitement de troubles neurodégénératifs
|
EP3355059A3
(fr)
|
2009-06-19 |
2018-09-26 |
Banyan Biomarkers, Inc. |
Analyse de biomarqueur de maladie neurologique
|
US20120142609A1
(en)
|
2009-06-26 |
2012-06-07 |
Abdoulaye Sene |
Non human animal models for increased retinal vascular permeability
|
AU2013203588C1
(en)
*
|
2009-07-09 |
2016-06-30 |
Somalogic Operating Co., Inc. |
Method for generating aptamers with improved off-rates
|
AR077595A1
(es)
|
2009-07-27 |
2011-09-07 |
Genentech Inc |
Tratamientos de combinacion
|
GB0913258D0
(en)
|
2009-07-29 |
2009-09-02 |
Dynex Technologies Inc |
Reagent dispenser
|
US9523701B2
(en)
|
2009-07-29 |
2016-12-20 |
Dynex Technologies, Inc. |
Sample plate systems and methods
|
FR2948665B1
(fr)
|
2009-07-31 |
2011-09-23 |
Lfb Biotechnologies |
Procede pour la purification de proteines de la coagulation a domaine gla actives
|
FR2948664B1
(fr)
|
2009-07-31 |
2013-11-01 |
Lfb Biotechnologies |
Procede pour la purification de proteines de la coagulation a domaine gla
|
US9250234B2
(en)
|
2011-01-19 |
2016-02-02 |
Ohmx Corporation |
Enzyme triggered redox altering chemical elimination (E-TRACE) immunoassay
|
CA2770071C
(fr)
|
2009-08-07 |
2014-07-15 |
Ohmx Corporation |
Immuno-essai d'elimination chimique a modification redox declenchee par une enzyme (e-trace)
|
GB0914318D0
(en)
|
2009-08-14 |
2009-09-30 |
Medical Res Council |
Method
|
US8898069B2
(en)
*
|
2009-08-28 |
2014-11-25 |
The Invention Science Fund I, Llc |
Devices and methods for detecting an analyte in salivary fluid
|
US9024766B2
(en)
*
|
2009-08-28 |
2015-05-05 |
The Invention Science Fund, Llc |
Beverage containers with detection capability
|
WO2011026111A1
(fr)
|
2009-08-31 |
2011-03-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Distribution par voie orale d'un vaccin au gros intestin pour induire une immunité mucosale
|
WO2011023824A2
(fr)
|
2009-08-31 |
2011-03-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Modulateurs de récepteur oestrogénique pour le traitement de maladies impliquant les cellules dendritiques plasmacytoïdes
|
JP5909447B2
(ja)
|
2009-09-14 |
2016-04-26 |
バンヤン・バイオマーカーズ・インコーポレーテッド |
ニューロン損傷診断のためのマイクロrna、自己抗体およびタンパク質マーカー
|
WO2011042564A1
(fr)
|
2009-10-09 |
2011-04-14 |
Universite De Strasbourg |
Nanomatériau marqué à base de silice à propriétés améliorées et ses utilisations
|
CA2777682C
(fr)
|
2009-10-13 |
2015-02-24 |
The Regents Of The University Of Michigan |
Compositions de dendrimeres et procedes de synthese
|
MX2012004638A
(es)
|
2009-10-22 |
2012-07-04 |
Genentech Inc |
Modulacion de degeneracion de axones.
|
US8912323B2
(en)
|
2009-10-30 |
2014-12-16 |
The Regents Of The University Of Michigan |
Multifunctional small molecules
|
US8841429B2
(en)
|
2009-11-03 |
2014-09-23 |
Vivonics, Inc. |
Nucleic acid ligands against infectious prions
|
US8236570B2
(en)
|
2009-11-03 |
2012-08-07 |
Infoscitex |
Methods for identifying nucleic acid ligands
|
US20120311728A1
(en)
|
2009-11-06 |
2012-12-06 |
Ziad Mallat |
Methods and pharmaceutical composition for the treatment of atherosclerosis
|
US11051744B2
(en)
|
2009-11-17 |
2021-07-06 |
Setpoint Medical Corporation |
Closed-loop vagus nerve stimulation
|
US9833621B2
(en)
|
2011-09-23 |
2017-12-05 |
Setpoint Medical Corporation |
Modulation of sirtuins by vagus nerve stimulation
|
WO2011061340A1
(fr)
|
2009-11-23 |
2011-05-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Inhibiteurs du complexe pp1/gadd34 pour le traitement d'un état nécessitant une activité d'immunosuppression
|
DE102009056944A1
(de)
|
2009-12-07 |
2011-06-09 |
Christian-Albrechts-Universität Zu Kiel |
RNA-Aptamere, die den löslichen Interleukin-6-Rezeptor spezifisch binden
|
DE102009056945A1
(de)
|
2009-12-07 |
2011-06-16 |
Christian-Albrechts-Universität Zu Kiel |
DNA-Aptamere, die den löslichen Interleukin-6-Rezeptor spezifisch binden
|
EP3636314B1
(fr)
|
2009-12-23 |
2021-09-08 |
Setpoint Medical Corporation |
Dispositifs et systèmes de stimulation neuronale pour le traitement de l'inflammation chronique
|
US10837883B2
(en)
|
2009-12-23 |
2020-11-17 |
Bio-Rad Laboratories, Inc. |
Microfluidic systems and methods for reducing the exchange of molecules between droplets
|
US20110165037A1
(en)
*
|
2010-01-07 |
2011-07-07 |
Ismagilov Rustem F |
Interfaces that eliminate non-specific adsorption, and introduce specific interactions
|
SI2523661T1
(sl)
|
2010-01-15 |
2017-09-29 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Nkcc inhibitorji za zdravljenje avtizma
|
GB2489187B
(en)
|
2010-01-20 |
2015-02-11 |
New England Biolabs Inc |
Compositions, methods and related uses for cleaving modified DNA
|
US20110201076A1
(en)
|
2010-01-22 |
2011-08-18 |
Colorado School Of Mines |
Harvesting micro algae
|
US20130149314A1
(en)
|
2010-02-09 |
2013-06-13 |
Jörn Bullerdiek |
p19Arf, HMGA2 and MDM2 For Use in the Diagnosis and Treatment of Aberrant Cell Growth
|
EP2535410A4
(fr)
|
2010-02-12 |
2014-08-13 |
Ribomic Inc |
Aptamère pour fgf2 et son utilisation
|
US9040287B2
(en)
|
2010-02-12 |
2015-05-26 |
Mediomics, Llc |
Molecular biosensors capable of signal amplification
|
JP5934657B2
(ja)
|
2010-02-12 |
2016-06-15 |
レインダンス テクノロジーズ, インコーポレイテッド |
デジタル検体分析
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9556249B2
(en)
|
2010-02-18 |
2017-01-31 |
Genentech, Inc. |
Neuregulin antagonists and use thereof in treating cancer
|
WO2011109379A1
(fr)
|
2010-03-01 |
2011-09-09 |
Quanterix Corporation |
Procédés et systèmes pour étendre la plage dynamique dans des dosages pour la détection de molécules ou de particules
|
US8236574B2
(en)
|
2010-03-01 |
2012-08-07 |
Quanterix Corporation |
Ultra-sensitive detection of molecules or particles using beads or other capture objects
|
US9678068B2
(en)
|
2010-03-01 |
2017-06-13 |
Quanterix Corporation |
Ultra-sensitive detection of molecules using dual detection methods
|
EP2542266A4
(fr)
|
2010-03-03 |
2013-10-23 |
Somalogic Inc |
Aptamères pouvant se lier à 4-1bb et utilisation associée dans le traitement de maladies et de troubles
|
WO2011113118A1
(fr)
|
2010-03-19 |
2011-09-22 |
Katholieke Universiteit Leuven |
Tolérance aux médicaments/persistance de biofilms fongiques
|
AU2011230388B2
(en)
|
2010-03-24 |
2016-09-08 |
Fujimoto Pharmaceutical Corporation |
Aptamer for NGF and use thereof
|
AU2011235892B2
(en)
|
2010-04-01 |
2016-07-07 |
Banyan Biomarkers, Inc. |
Markers and assays for detection of neurotoxicity
|
AU2011237851B2
(en)
|
2010-04-08 |
2015-02-05 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Inhibiting peptides derived from TREM-Like Transcript 1 (TLT-1) and uses thereof
|
US8598140B2
(en)
|
2010-04-12 |
2013-12-03 |
Somalogic, Inc. |
Aptamers to β-NGF and their use in treating β-NGF mediated diseases and disorders
|
EP2577309B1
(fr)
|
2010-05-25 |
2016-11-23 |
Carnegie Mellon University |
Sondes ciblées de physiologie cellulaire
|
WO2012002541A1
(fr)
|
2010-07-01 |
2012-01-05 |
独立行政法人産業技術総合研究所 |
Procédé de détection de molécule cible
|
EP2589653A1
(fr)
*
|
2010-07-02 |
2013-05-08 |
NEC Soft, Ltd. |
Dispositif de prévision, procédé de prévision, programme et support d'enregistrement
|
CN103153331B
(zh)
|
2010-07-15 |
2017-03-22 |
亚德赫伦医疗公司 |
靶向于钙粘着蛋白‑11的ec1结构域的人源化抗体及相关组合物和方法
|
US20130202652A1
(en)
|
2010-07-30 |
2013-08-08 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
EP2603587B1
(fr)
|
2010-08-09 |
2015-10-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Compositions pharmaceutiques pour le traitement et prevention des infections par le vih-1
|
EP2603607B1
(fr)
|
2010-08-11 |
2016-04-06 |
Celula, Inc. |
Genotypage d'adn
|
WO2012021913A1
(fr)
|
2010-08-18 |
2012-02-23 |
University Of Graz |
Procédés d'augmentation de la résistance des plantes à la sécheresse, au sel et aux agents pathogènes
|
WO2012022496A2
(fr)
|
2010-08-19 |
2012-02-23 |
Per Sonne Holm |
Procédé pour tuer des cellules souches tumorales
|
WO2012038448A1
(fr)
|
2010-09-21 |
2012-03-29 |
Riboxx Gmbh |
Procédé pour synthétiser de l'arn en utilisant une matrice d'adn
|
AU2011312491B2
(en)
|
2010-09-27 |
2015-06-04 |
Somalogic, Inc. |
Mesothelioma biomarkers and uses thereof
|
EP3447155A1
(fr)
|
2010-09-30 |
2019-02-27 |
Raindance Technologies, Inc. |
Dosages en sandwich dans des gouttelettes
|
WO2012051519A2
(fr)
|
2010-10-14 |
2012-04-19 |
The Johns Hopkins University |
Biomarqueurs d'une lésion cérébrale
|
SG189856A1
(en)
|
2010-10-14 |
2013-06-28 |
Regado Biosciences Inc |
Nucleic acid modulators of clec-2
|
EP3266881B1
(fr)
|
2010-11-05 |
2019-12-25 |
Genalyte, Inc. |
Systèmes de détection d'analytes optiques et procédés d'utilisation
|
WO2012068463A2
(fr)
|
2010-11-18 |
2012-05-24 |
Beth Israel Deaconess Medicall Center, Inc. |
Méthodes de traitement de l'obésité par inhibition de la nicotinamide n-méthyltransférase (nnmt)
|
US20140056811A1
(en)
|
2010-12-27 |
2014-02-27 |
Compugen Ltd. |
New cell-penetrating peptides and uses thereof
|
EP2663640B1
(fr)
|
2011-01-10 |
2020-11-04 |
APTARION biotech AG |
Molécule d'acide nucléique ayant une affinité de liaison vis-à-vis d'une molécule cible et son procédé de génération
|
AR085087A1
(es)
|
2011-01-21 |
2013-09-11 |
Theranos Inc |
Sistemas y metodos para maximizar el uso de muestras
|
EP2673301A2
(fr)
|
2011-02-09 |
2013-12-18 |
Cancer Research Technology Limited |
Antagonistes de frmd4a et leurs utilisations
|
WO2012109600A2
(fr)
|
2011-02-11 |
2012-08-16 |
Raindance Technologies, Inc. |
Procédés de formation de gouttelettes mélangées
|
EP2675819B1
(fr)
|
2011-02-18 |
2020-04-08 |
Bio-Rad Laboratories, Inc. |
Compositions et méthodes de marquage moléculaire
|
US20140010886A1
(en)
|
2011-04-07 |
2014-01-09 |
Georgia Tech Research Corporation |
Compositions comprising saccharide binding moieties and methods for targeted therapy
|
JP6347743B2
(ja)
|
2011-05-05 |
2018-06-27 |
マティナス バイオファーマ ナノテクノロジーズ,インコーポレーテッド |
コクリエート組成物およびその製造および使用方法
|
WO2012152711A1
(fr)
|
2011-05-06 |
2012-11-15 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Procédés d'identification d'aptamères
|
JP2014518624A
(ja)
|
2011-05-12 |
2014-08-07 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
ニューログラニン診断キットのためのアッセイ試薬
|
WO2012156476A2
(fr)
|
2011-05-16 |
2012-11-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Procédés pour identifier par criblage des substances capables de moduler la réplication d'un virus de la grippe
|
AR086543A1
(es)
|
2011-05-25 |
2014-01-08 |
Bg Medicine Inc |
Inhibidores de galectina-3 y metodos de uso de los mismos, composicion farmaceutica
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
EP2714970B1
(fr)
|
2011-06-02 |
2017-04-19 |
Raindance Technologies, Inc. |
Quantification d'enzyme
|
GB201110371D0
(en)
|
2011-06-17 |
2011-08-03 |
Proteome Sciences R & D Gmbh & Co Kg |
Materials and methods for determining sensitivity potential of compounds
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
WO2013014073A1
(fr)
|
2011-07-22 |
2013-01-31 |
Universite De Strasbourg |
Conjugués de phospholipide-détergent et leurs utilisations
|
MY193562A
(en)
|
2011-08-01 |
2022-10-19 |
Genentech Inc |
Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors
|
US20140194320A1
(en)
|
2011-08-12 |
2014-07-10 |
Tagcyx Bitoecnologies |
Method for preparing nucleic acid aptamer
|
GB201114662D0
(en)
|
2011-08-24 |
2011-10-12 |
Altermune Technologies Llc |
Chemically programmable immunity
|
WO2013034579A1
(fr)
|
2011-09-05 |
2013-03-14 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Groupe de gènes biosynthétiques pour la production d'analogues de peptides/de protéines
|
WO2013034687A1
(fr)
|
2011-09-09 |
2013-03-14 |
Universität Bern Verwaltungsdirektion |
Toxine rtx d'avibacterium paragallinarum
|
US9664702B2
(en)
|
2011-09-25 |
2017-05-30 |
Theranos, Inc. |
Fluid handling apparatus and configurations
|
US9619627B2
(en)
|
2011-09-25 |
2017-04-11 |
Theranos, Inc. |
Systems and methods for collecting and transmitting assay results
|
US9632102B2
(en)
|
2011-09-25 |
2017-04-25 |
Theranos, Inc. |
Systems and methods for multi-purpose analysis
|
US9268915B2
(en)
|
2011-09-25 |
2016-02-23 |
Theranos, Inc. |
Systems and methods for diagnosis or treatment
|
US8435738B2
(en)
|
2011-09-25 |
2013-05-07 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
US8475739B2
(en)
|
2011-09-25 |
2013-07-02 |
Theranos, Inc. |
Systems and methods for fluid handling
|
US8840838B2
(en)
|
2011-09-25 |
2014-09-23 |
Theranos, Inc. |
Centrifuge configurations
|
US20140170735A1
(en)
|
2011-09-25 |
2014-06-19 |
Elizabeth A. Holmes |
Systems and methods for multi-analysis
|
WO2013040577A1
(fr)
|
2011-09-16 |
2013-03-21 |
The Research Foundation Of State University Of New York |
Aptamères résistant à la dégradation par la nucléocapside
|
SG11201400724SA
(en)
|
2011-09-19 |
2014-04-28 |
Genentech Inc |
Combination treatments comprising c-met antagonists and b-raf antagonists
|
US9810704B2
(en)
|
2013-02-18 |
2017-11-07 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
US9250229B2
(en)
|
2011-09-25 |
2016-02-02 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
US10012664B2
(en)
|
2011-09-25 |
2018-07-03 |
Theranos Ip Company, Llc |
Systems and methods for fluid and component handling
|
AU2012317323B2
(en)
*
|
2011-09-28 |
2017-10-05 |
Fujimoto Pharmaceutical Corporation |
NGF aptamer and application thereof
|
WO2013049405A1
(fr)
|
2011-09-30 |
2013-04-04 |
Mallinckrodt Llc |
Ensemble distant de nanoparticules ciblées utilisant des liants oligonucléotidiques complémentaires
|
WO2013050540A1
(fr)
|
2011-10-05 |
2013-04-11 |
University Of Bremen |
Wnt4 et med12 pour l'utilisation dans le diagnostic et le traitement de maladies tumorales
|
JP6203183B2
(ja)
|
2011-10-17 |
2017-09-27 |
オームクス コーポレイション |
酵素誘発レドックス変化化学的脱離(e−trace)イムノアッセイを使用する、ヘモグロビンa1cのパーセンテージの単回直接検出
|
JP2015504413A
(ja)
|
2011-10-28 |
2015-02-12 |
パトリス リミテッド |
Pat−lm1エピトープおよびそれを使用するための方法
|
DK2773958T3
(en)
|
2011-11-02 |
2018-03-12 |
Univ Cape Town |
Method for identifying an analyte in a biological sample
|
CA2854459A1
(fr)
|
2011-11-04 |
2013-05-10 |
Ohmx Corporation |
Nouvelle chimie utilisee dans des biocapteurs
|
SG11201402402SA
(en)
|
2011-11-18 |
2014-09-26 |
Tagcyx Biotechnologies |
Nucleic acid fragment binding to target protein
|
FR2983212A1
(fr)
|
2011-11-28 |
2013-05-31 |
Lfb Biotechnologies |
Aptameres anti-fh, procede pour leur obtention et utilisations
|
EP2785839A2
(fr)
|
2011-11-30 |
2014-10-08 |
University of Bremen |
Expression d'arnmi dans le tissu placentaire
|
WO2013085718A1
(fr)
|
2011-12-08 |
2013-06-13 |
The Regents Of The University Of Michigan |
Petites molécules multifonctionnelles
|
EP2802669A1
(fr)
|
2012-01-09 |
2014-11-19 |
Ohmx Corporation |
Procédés enzymatiques en cascade pour l'amplification du signal d'un dosage de trace e
|
CN104379724B
(zh)
|
2012-01-31 |
2018-01-02 |
托莱多大学 |
用于分析物的检测和测量的方法和装置
|
WO2013119602A1
(fr)
|
2012-02-06 |
2013-08-15 |
President And Fellows Of Harvard College |
Microvésicules médiées par arrdc1 (armm) et leurs utilisations
|
FR2987627B1
(fr)
|
2012-03-05 |
2016-03-18 |
Splicos |
Utilisation de rbm39 comme biomarqueur
|
WO2013138251A1
(fr)
|
2012-03-12 |
2013-09-19 |
The Board Of Trustes Of The University Of Illinois |
Systèmes optiques de détection d'analyte avec amplification magnétique et procédés d'utilisation
|
WO2013142255A2
(fr)
|
2012-03-22 |
2013-09-26 |
University Of Miami |
Agents de liaison multi-spécifiques
|
US9572983B2
(en)
|
2012-03-26 |
2017-02-21 |
Setpoint Medical Corporation |
Devices and methods for modulation of bone erosion
|
WO2013152252A1
(fr)
|
2012-04-06 |
2013-10-10 |
OSI Pharmaceuticals, LLC |
Polythérapie antinéoplasique
|
WO2013170960A1
(fr)
|
2012-05-16 |
2013-11-21 |
Silence Therapeutics Ag |
Utilisation de vegfr1 en tant que biomarqueur pour l'administration d'un inhibiteur de pkn3
|
US10138479B2
(en)
|
2012-05-24 |
2018-11-27 |
Dana-Farber Cancer Institute, Inc. |
Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
|
US20150141259A1
(en)
|
2012-06-07 |
2015-05-21 |
Somalogic, Inc. |
Aptamer-Based Multiplexed Assays
|
US9211185B2
(en)
|
2012-06-13 |
2015-12-15 |
Elwha Llc |
Breast implant with analyte sensors and internal power source
|
US9144488B2
(en)
|
2012-06-13 |
2015-09-29 |
Elwha Llc |
Breast implant with analyte sensors responsive to external power source
|
US8808373B2
(en)
|
2012-06-13 |
2014-08-19 |
Elwha Llc |
Breast implant with regionalized analyte sensors responsive to external power source
|
US9144489B2
(en)
|
2012-06-13 |
2015-09-29 |
Elwha Llc |
Breast implant with covering, analyte sensors and internal power source
|
US8790400B2
(en)
|
2012-06-13 |
2014-07-29 |
Elwha Llc |
Breast implant with covering and analyte sensors responsive to external power source
|
US8795359B2
(en)
|
2012-06-13 |
2014-08-05 |
Elwha Llc |
Breast implant with regionalized analyte sensors and internal power source
|
CA2876165C
(fr)
|
2012-06-25 |
2021-06-15 |
Emory University |
Conjugues particule-acide nucleique et utilisations therapeutiques associees
|
SG10201912895PA
(en)
|
2012-07-13 |
2020-02-27 |
Wave Life Sciences Ltd |
Chiral control
|
US20150285802A1
(en)
|
2012-07-18 |
2015-10-08 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating, preventing and predicting risk of developing breast cancer
|
CN112587658A
(zh)
|
2012-07-18 |
2021-04-02 |
博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
EP2877851A1
(fr)
|
2012-07-27 |
2015-06-03 |
Ohmx Corporation |
Mesure électrique de monocouches après détection pro-clivage de la présence et de l'activité d'enzymes et d'autres analytes cibles
|
US9404883B2
(en)
|
2012-07-27 |
2016-08-02 |
Ohmx Corporation |
Electronic measurements of monolayers following homogeneous reactions of their components
|
WO2014019099A1
(fr)
|
2012-07-31 |
2014-02-06 |
Juan Carlos Jaime |
Procédé pour obtenir et détecter un marqueur d'objets à identifier, marqueur y relatif, procédé d'authentifier et procédé de vérification
|
KR20150085806A
(ko)
|
2012-08-02 |
2015-07-24 |
디킨 유니버시티 |
암 줄기세포 검출을 위한 cd133 앱타머
|
CA2880833A1
(fr)
|
2012-08-03 |
2014-02-06 |
Aptamir Therapeutics, Inc. |
Administration cellulaire specifique de modulateurs de miarn pour le traitement de l'obesite et de troubles associes
|
AU2013204200B2
(en)
|
2012-10-11 |
2016-10-20 |
Brandeis University |
Treatment of amyotrophic lateral sclerosis
|
DE102012020496A1
(de)
|
2012-10-18 |
2014-04-24 |
Charité - Universitätsmedizin Berlin |
Biomarker zur Diagnostik und Behandlung von Neurofibromatose Typ 1
|
BR112015009138A2
(pt)
|
2012-10-23 |
2020-10-20 |
Caris Life Sciences Switzerland Holdings, S.A.R.L. |
métodos para caracterizar um câncer
|
US10942184B2
(en)
|
2012-10-23 |
2021-03-09 |
Caris Science, Inc. |
Aptamers and uses thereof
|
EP3427830B1
(fr)
|
2012-10-24 |
2021-06-23 |
Genmark Diagnostics Inc. |
Analyse de cibles multiplexes intégrées
|
EP4035689A1
(fr)
|
2012-12-13 |
2022-08-03 |
Immunomedics Inc. |
Dosages d'immuno-conjugués d'anticorps et de sn-38 pour améliorer l'efficacité et réduire la toxicité
|
EP2935628B1
(fr)
|
2012-12-19 |
2018-03-21 |
Caris Life Sciences Switzerland Holdings GmbH |
Compositions et procédés pour le criblage d'aptamères
|
FR3000105B1
(fr)
|
2012-12-24 |
2015-05-15 |
Lvmh Rech |
Aptameres inhibiteurs de l'activite enzymatique de la tyrosinase
|
US9731032B2
(en)
|
2013-02-04 |
2017-08-15 |
The Cleveland Clinic Foundation |
Aptamers for tumor initiating cells
|
US20150379197A1
(en)
|
2013-02-15 |
2015-12-31 |
Nec Solution Innovators, Ltd. |
Selection device for candidate sequence information for similarity determination, selection method, and use for such device and method
|
EP2774930A1
(fr)
|
2013-03-07 |
2014-09-10 |
Aptenia S.R.L. |
Composés de métallocène et molécules marquées comprenant ceux-ci pour l'imagerie in vivo
|
BR112015023098A2
(pt)
|
2013-03-14 |
2017-07-18 |
Univ Jefferson |
agentes de infrarregulação do receptor de andrógeno e usos dos mesmos
|
US9052314B2
(en)
|
2013-03-14 |
2015-06-09 |
Silver Lake Research Corporation |
Biomarkers for detecting the presence of bacteria
|
US9983206B2
(en)
|
2013-03-15 |
2018-05-29 |
The Board Of Trustees Of The University Of Illinois |
Methods and compositions for enhancing immunoassays
|
DK2970915T3
(da)
|
2013-03-15 |
2019-11-11 |
Maxcyte Inc |
Fremgangsmåder og sammensætninger til generering af stabile transficerede celler
|
WO2014150198A2
(fr)
|
2013-03-15 |
2014-09-25 |
Somalogic, Inc. |
Biomarqueurs de stéatose hépatique non-alcoolique (nafld) et de stéatohépatite non-alcoolique (nash) et utilisations associées
|
US9850492B2
(en)
|
2013-03-22 |
2017-12-26 |
The University Of Tokyo |
Aptamer to IL-17 and use thereof
|
CN105264374A
(zh)
|
2013-03-27 |
2016-01-20 |
赛拉诺斯股份有限公司 |
用于样品分析的方法、装置和系统
|
CN105247561A
(zh)
|
2013-05-23 |
2016-01-13 |
艾弗诺泰普有限责任公司 |
用于协助个人、产品提供者和/或服务提供者的方法和系统
|
GB201310203D0
(en)
|
2013-06-07 |
2013-07-24 |
Electrophoretics Ltd |
Materials and methods relating to Alzheimer's disease
|
CA2915149C
(fr)
|
2013-06-12 |
2019-02-05 |
The Governing Council Of The University Of Toronto |
Acide nucleique catalytique et nanoparticules d'or pour la detection de biomolecules
|
EP3587585B1
(fr)
|
2013-06-12 |
2021-03-24 |
The General Hospital Corporation |
Procédés, kits et systèmes de détection multiplexée de molécules cibles et leurs utilisations
|
WO2014201265A1
(fr)
|
2013-06-14 |
2014-12-18 |
Pacific Biosciences Of California, Inc. |
Étiquettes de bis-biotinylation
|
AU2014302038B2
(en)
|
2013-06-25 |
2019-11-14 |
Epiaxis Therapeutics Pty Ltd |
Methods and compositions for modulating cancer stem cells
|
WO2014210219A1
(fr)
*
|
2013-06-25 |
2014-12-31 |
Two Pore Guys, Inc. |
Quantification de biomarqueurs multiplexés par l'analyse de nanopores de complexes biomarqueur-polymère
|
US20150017163A1
(en)
|
2013-07-12 |
2015-01-15 |
Ophthotech Corporation |
Methods for Treating or Preventing Ophthalmological Conditions
|
PL3021869T3
(pl)
|
2013-07-16 |
2020-11-16 |
F. Hoffmann-La Roche Ag |
Sposoby leczenia nowotworu z użyciem antagonistów wiązania osi PD-1 i inhibitorów TIGIT
|
US10534003B2
(en)
|
2013-07-17 |
2020-01-14 |
The Johns Hopkins University |
Multi-protein biomarker assay for brain injury detection and outcome
|
CN105636594A
(zh)
|
2013-08-12 |
2016-06-01 |
托凯药业股份有限公司 |
使用雄激素靶向疗法用于治疗肿瘤性疾病的生物标记物
|
GB201314485D0
(en)
|
2013-08-13 |
2013-09-25 |
Electrophoretics Ltd |
Materials and methods relating to pancreatic cancer
|
EP2837939A1
(fr)
|
2013-08-13 |
2015-02-18 |
Technische Universität München |
Procédé pour la détection de l'infection par H.pylori
|
BR102013021701A2
(pt)
|
2013-08-26 |
2015-07-28 |
Univ São Paulo Usp |
Polinucleotídeos quimicamente modificados e processo de produção de polinucleotídeos quimicamente modificados
|
EP3039174B1
(fr)
|
2013-08-28 |
2019-10-16 |
Caris Science, Inc. |
Sondes oligonucléotidiques et leurs utilisations
|
GB201315743D0
(en)
|
2013-09-04 |
2013-10-16 |
Maersk Olie & Gas |
Provision and uses of wettability modifiers
|
US11545241B1
(en)
|
2013-09-07 |
2023-01-03 |
Labrador Diagnostics Llc |
Systems and methods for analyte testing and data management
|
EP3044334B1
(fr)
|
2013-09-09 |
2020-08-12 |
Somalogic, Inc. |
Aptamères de pdgf et vegf présentant une stabilité améliorée et leur utilisation dans le traitement de maladies et de troubles médiés par pdgf et vegf
|
US10016424B2
(en)
|
2013-09-16 |
2018-07-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale |
Method and pharmaceutical composition for use in the treatment of epilepsy
|
AU2014324092B2
(en)
|
2013-09-18 |
2020-02-06 |
Epiaxis Therapeutics Pty Ltd |
Stem cell modulation II
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
ES2784234T3
(es)
|
2013-10-08 |
2020-09-23 |
Promedior Inc |
Métodos para el tratamiento de cánceres fibróticos
|
US20170233737A1
(en)
|
2013-11-04 |
2017-08-17 |
Noxxon Pharma Ag |
Means and Methods for the Treatment of Nephropathy
|
JP2016539639A
(ja)
|
2013-11-13 |
2016-12-22 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
キッシング複合体を形成することができる核酸を含むキットオブパーツ及びその使用
|
GB201320061D0
(en)
|
2013-11-13 |
2013-12-25 |
Electrophoretics Ltd |
Materials nad methods for diagnosis and prognosis of liver cancer
|
US9938314B2
(en)
|
2013-11-21 |
2018-04-10 |
Somalogic, Inc. |
Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto
|
AR093574A1
(es)
|
2013-11-21 |
2015-06-10 |
Consejo Nac De Investig Cientificas Y Tecn (Conicet) |
Aptameros contra la proteina basica de mielina como agentes neuroprotectores
|
DE102013112915A1
(de)
|
2013-11-22 |
2015-05-28 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
DNA-Aptamere, die E- und P-Selektine spezifisch binden
|
EP3076950A1
(fr)
|
2013-12-05 |
2016-10-12 |
Silence Therapeutics GmbH |
Moyen de délivrance pulmonaire spécifique
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
BR112016013741A2
(pt)
|
2013-12-17 |
2017-10-03 |
Genentech Inc |
Usos de antagonistas de ligação de eixo de pd-1 e um anticorpo de anti-cd20, e kit compreendendo os mesmos
|
WO2015103367A1
(fr)
|
2013-12-31 |
2015-07-09 |
Raindance Technologies, Inc. |
Système et procédé de détection d'une espèce d'arn
|
CA2936377A1
(fr)
|
2014-01-10 |
2015-07-16 |
Shanghai Birdie Biotech, Inc. |
Composes et compositions pour le traitement de tumeurs exprimant egfr
|
JP6636436B2
(ja)
|
2014-02-05 |
2020-01-29 |
ディーキン・ユニバーシティー |
アプタマー構築体
|
WO2015120382A1
(fr)
|
2014-02-07 |
2015-08-13 |
The Johns Hopkins University |
Prédiction de réponse à un traitement utilisant des médicaments épigénétiques
|
CN116334088A
(zh)
|
2014-02-18 |
2023-06-27 |
私募蛋白质体运营有限公司 |
用于检测微生物的组合物和方法
|
US10307472B2
(en)
|
2014-03-12 |
2019-06-04 |
Curevac Ag |
Combination of vaccination and OX40 agonists
|
EP3119435A1
(fr)
|
2014-03-17 |
2017-01-25 |
GlaxoSmithKline Intellectual Property Development Limited |
Aptamères pour administration topique
|
EP3119913B1
(fr)
|
2014-03-21 |
2021-01-06 |
The Brigham and Women's Hospital, Inc. |
Procédés et compositions pour le traitement de maladies immunitaires ou de troubles et/ou la surveillance thérapeutique
|
RU2016141385A
(ru)
|
2014-03-24 |
2018-04-28 |
Дженентек, Инк. |
Лечение рака антагонистами с-мет и их корреляция с экспрессией hgf
|
HUE048529T2
(hu)
|
2014-03-24 |
2020-07-28 |
Ribomic Inc |
FGF2-hez kötõdõ aptamer és alkalmazása
|
WO2015149006A2
(fr)
|
2014-03-27 |
2015-10-01 |
Dana-Farber Cancer Institute, Inc. |
Compositions et procédés de modulation du ciblage autophagique de la ferritine médié par ncoa4
|
EP3808778A1
(fr)
|
2014-04-18 |
2021-04-21 |
Acceleron Pharma Inc. |
Procédés d'augmentation des taux de globules rouges et de traitement de la drépanocytose
|
WO2015164616A1
(fr)
|
2014-04-24 |
2015-10-29 |
Somalogic, Inc. |
Biomarqueurs de détection de la tuberculose
|
WO2015164617A1
(fr)
|
2014-04-24 |
2015-10-29 |
Somalogic, Inc. |
Biomarqueurs de la tuberculose dans l'urine et leurs utilisations
|
CN106662583A
(zh)
|
2014-04-29 |
2017-05-10 |
Ohmx公司 |
使用峰曲线的生物电子结合测定
|
CA2951926C
(fr)
|
2014-06-13 |
2023-01-10 |
Acceleron Pharma, Inc. |
Methodes et compositions de traitement d'ulceres
|
CN105233291A
(zh)
|
2014-07-09 |
2016-01-13 |
博笛生物科技有限公司 |
用于治疗癌症的联合治疗组合物和联合治疗方法
|
KR102462743B1
(ko)
|
2014-07-09 |
2022-11-02 |
버디 바이오파마슈티칼즈, 인크. |
종양 치료용 항-pd-l1 조합
|
PL3169361T3
(pl)
|
2014-07-15 |
2019-11-29 |
Hoffmann La Roche |
Kompozycje do leczenia nowotworu z użyciem związków antagonistycznych wiązania osi pd-1 i inhibitorów mek
|
WO2016025539A1
(fr)
|
2014-08-11 |
2016-02-18 |
Ohmx Corporation |
Dosage d'elimination chimique modifiant le potentiel redox declenchee par une enzyme (-trace) a fonctions de multiplexage
|
EP3182917A1
(fr)
|
2014-08-20 |
2017-06-28 |
Memorial Sloan Kettering Cancer Center |
Systèmes et procédés d'ablation/résection déclenchés par un rapporteur raman
|
RU2708237C2
(ru)
|
2014-08-22 |
2019-12-05 |
Общество с ограниченной ответственностью "НооГен" |
Модифицированные олигонуклеотиды и способ их получения
|
CA2958704A1
(fr)
|
2014-08-25 |
2016-03-03 |
University Of Canberra |
Compositions pour moduler les cellules souches cancereuses et leurs utilisations
|
CN107106704A
(zh)
|
2014-08-29 |
2017-08-29 |
儿童医疗中心有限公司 |
用于治疗癌症的方法和组合物
|
CN112587672A
(zh)
|
2014-09-01 |
2021-04-02 |
博笛生物科技有限公司 |
用于治疗肿瘤的抗-pd-l1结合物
|
EP3191843A1
(fr)
|
2014-09-12 |
2017-07-19 |
Mediomics, LLC |
Biocapteurs moléculaires présentant une conception modulaire
|
US10222386B2
(en)
|
2014-09-19 |
2019-03-05 |
The Johns Hopkins University |
Biomarkers of congnitive dysfunction
|
KR102328327B1
(ko)
|
2014-09-26 |
2021-11-22 |
소마로직, 인크. |
심혈관 위험 사건 예측 및 이의 용도
|
EP3000483A1
(fr)
|
2014-09-29 |
2016-03-30 |
Charité - Universitätsmedizin Berlin |
Moyens et procédés pour le diagnostic et le traitement de maladies neurodégénératives
|
DE102014114834A1
(de)
|
2014-10-13 |
2016-04-14 |
Centrum Für Angewandte Nanotechnologie (Can) Gmbh |
Nanopartikel enthaltende Polymermizellen in nicht-wässriger Lösung, Methoden zu ihrer Herstellung und ihrer Anwendung
|
WO2016061460A1
(fr)
|
2014-10-17 |
2016-04-21 |
Carnegie Mellon University |
Dosages améliorés pour la détection de biomolécules basés sur l'amplification du signal par tyramide et des sondes de gamma-pna
|
US11311725B2
(en)
|
2014-10-24 |
2022-04-26 |
Setpoint Medical Corporation |
Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
|
US9816080B2
(en)
|
2014-10-31 |
2017-11-14 |
President And Fellows Of Harvard College |
Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
|
RU2017119428A
(ru)
|
2014-11-06 |
2018-12-06 |
Дженентек, Инк. |
Комбинированная терапия, включающая применение агонистов, связывающихся с ох40, и ингибиторов tigit
|
FR3028527A1
(fr)
|
2014-11-13 |
2016-05-20 |
Pivert |
Identification de facteurs de transcription de yarrowia lipolytica
|
WO2016075314A1
(fr)
|
2014-11-13 |
2016-05-19 |
Institut National De La Recherche Agronomique |
Identification de facteurs de transcription de yarrowia lipolytica affectant la production de proteines
|
US10434177B2
(en)
|
2014-11-17 |
2019-10-08 |
Carnegie Mellon University |
Activatable two-component photosensitizers
|
MX2017006521A
(es)
|
2014-11-24 |
2017-08-09 |
Somalogic Inc |
Compuestos de acido nucleico para unirse al factor de diferenciacion de crecimiento 11.
|
MA41119A
(fr)
|
2014-12-03 |
2017-10-10 |
Acceleron Pharma Inc |
Méthodes de traitement de syndromes myélodysplasiques et d'anémie sidéroblastique
|
EP3970748A1
(fr)
|
2014-12-24 |
2022-03-23 |
NexImmune, Inc. |
Compositions de nanoparticules et méthodes pour l'immunothérapie
|
WO2016123058A1
(fr)
|
2015-01-27 |
2016-08-04 |
Somalogic, Inc. |
Biomarqueurs pour la détection du risque de tuberculose
|
AU2016215454B2
(en)
|
2015-02-02 |
2022-05-19 |
Meiragtx Uk Ii Limited |
Regulation of gene expression by aptamer-mediated modulation of alternative splicing
|
US11406833B2
(en)
|
2015-02-03 |
2022-08-09 |
Setpoint Medical Corporation |
Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
|
WO2016130414A1
(fr)
|
2015-02-09 |
2016-08-18 |
Somalogic, Inc. |
Composés d'acides nucléiques destinés à se lier à un facteur de croissance et de différenciation de type 8
|
WO2016134365A1
(fr)
|
2015-02-20 |
2016-08-25 |
The Johns Hopkins University |
Biomarqueurs de blessure myocardique
|
WO2016135300A1
(fr)
|
2015-02-26 |
2016-09-01 |
Qiagen Gmbh |
Procédés d'amélioration d'efficacité de génération d'une bibliothèque de gènes
|
WO2016134521A1
(fr)
|
2015-02-27 |
2016-09-01 |
The University Of Hong Kong |
Affichage d'adn et procédés associés
|
US10620185B2
(en)
|
2015-02-27 |
2020-04-14 |
Aptascan, Inc. |
Molecular barcoded bi-stable switch
|
WO2016138231A2
(fr)
|
2015-02-27 |
2016-09-01 |
Sauder Timothy Lee |
Commutateur bi-stable moléculaire à code à barres
|
US20180066262A1
(en)
|
2015-03-09 |
2018-03-08 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
EP3268011B1
(fr)
|
2015-03-12 |
2020-04-22 |
The Regents of The University of Michigan |
Aptamères de dek destinés au traitement de l'inflammation
|
EP3279325A4
(fr)
*
|
2015-03-30 |
2018-11-21 |
Nissan Chemical Corporation |
Aptamère d'acide nucléique capable de liaison au récepteur du facteur de croissance endothéliale vasculaire
|
US9968523B2
(en)
|
2015-03-30 |
2018-05-15 |
Elwha Llc |
Systems and devices for controlling delivery of breast milk supplementation
|
US10290372B2
(en)
|
2015-03-30 |
2019-05-14 |
Elwha Llc |
Systems and devices for controlling delivery of breast milk supplementation
|
US9925122B2
(en)
|
2015-03-30 |
2018-03-27 |
Elwha Llc |
Systems and methods for controlling delivery of breast milk supplementation
|
US10016341B2
(en)
|
2015-03-30 |
2018-07-10 |
Elwha Llc |
Systems and devices for controlling delivery of breast milk supplementation
|
RU2712610C2
(ru)
|
2015-04-03 |
2020-01-29 |
Эбботт Лэборетриз |
Устройства и способы для анализа образца
|
CN107690582B
(zh)
|
2015-04-03 |
2023-10-20 |
雅培制药有限公司 |
用于样品分析的装置和方法
|
MA41919A
(fr)
|
2015-04-06 |
2018-02-13 |
Acceleron Pharma Inc |
Hétéromultimères alk4:actriib et leurs utilisations
|
ES2863564T3
(es)
|
2015-04-06 |
2021-10-11 |
Acceleron Pharma Inc |
Heteromultímeros ALK7:ActRIIB y usos de los mismos
|
KR20170135966A
(ko)
|
2015-04-13 |
2017-12-08 |
맥스시티 인코포레이티드 |
게놈 dna를 변형시키기 위한 방법 및 조성물
|
WO2016182967A1
(fr)
|
2015-05-08 |
2016-11-17 |
Somalogic, Inc. |
Biomarqueurs pour la détection du risque de tuberculose
|
US20180153884A1
(en)
|
2015-05-31 |
2018-06-07 |
Curegenix Corporation |
Combination compositions for immunotherapy
|
EP3302710A4
(fr)
|
2015-06-03 |
2019-02-20 |
The University of Queensland |
Agents mobilisateurs et leurs utilisations
|
JP2018518169A
(ja)
|
2015-06-05 |
2018-07-12 |
レグルス セラピューティクス インコーポレイテッド |
非アルコール性脂肪肝疾患バイオマーカー
|
PT3313443T
(pt)
|
2015-06-25 |
2023-08-30 |
Immunomedics Inc |
Combinação de anticorpos anti-hla-dr ou anti-trop-2 com inibidores de microtúbulos, inibidores de parp, inibidores de bruton quinase ou inibidores de fosfoinositídeo 3-quinase melhora significativamente o resultado terapêutico no cancro
|
EP3314027A4
(fr)
|
2015-06-29 |
2019-07-03 |
Caris Science, Inc. |
Oligonucléotides thérapeutiques
|
WO2017004463A1
(fr)
|
2015-07-01 |
2017-01-05 |
Abbott Laboratories |
Dispositifs et procédés d'analyse d'échantillon
|
WO2017019729A1
(fr)
|
2015-07-27 |
2017-02-02 |
The General Hospital Corporation |
Dérivés d'anticorps présentant une fonction effectrice activée de manière conditionnelle
|
AU2016298317B2
(en)
|
2015-07-28 |
2021-02-18 |
Caris Science, Inc. |
Targeted oligonucleotides
|
MX2018001511A
(es)
|
2015-08-04 |
2018-08-01 |
Univ Duke |
Polimeros furtivos desordenados de forma intrinseca codificados geneticamente para suministro y metodos para usar los mismos.
|
KR20180035884A
(ko)
|
2015-08-04 |
2018-04-06 |
악셀레론 파마 인코포레이티드 |
골수증식성 장애를 치료하기 위한 방법
|
WO2017176265A1
(fr)
|
2016-04-06 |
2017-10-12 |
Mayo Foundation For Medical Education And Research |
Compositions de support-agent de liaison et leurs procédés de fabrication et d'utilisation
|
CA2997179A1
(fr)
|
2015-09-02 |
2017-03-09 |
The Regents Of The Unversity Of Colorado, A Body Corporate |
Compositions et procedes de modulation d'une reponse immunitaire a lymphocytes t
|
JP2018526030A
(ja)
|
2015-09-04 |
2018-09-13 |
ネオベンチャーズ バイオテクノロジー インコーポレイテッド |
結合していない標的についてのアプタマーの選抜のための方法
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
EP3347720A1
(fr)
|
2015-09-09 |
2018-07-18 |
Somalogic, Inc. |
Méthodes destinées à développer des plans de traitements médicamenteux personnalisés et développement de médicaments ciblés basés sur des profils protéomiques
|
KR20200087283A
(ko)
|
2015-09-25 |
2020-07-20 |
제넨테크, 인크. |
항-tigit 항체 및 이의 이용 방법
|
EP3371311B1
(fr)
|
2015-11-06 |
2021-07-21 |
Orionis Biosciences BV |
Protéines chimères bifonctionnelles et leurs utilisations
|
SG10202004259PA
(en)
|
2015-11-19 |
2020-06-29 |
Asclepix Therapeutics Llc |
Peptides with anti-angiogenic, anti-lymphangiogenic, and anti-edemic properties and nanoparticle formulations
|
EP3380121B1
(fr)
|
2015-11-23 |
2023-12-20 |
Acceleron Pharma Inc. |
Actrii antagoniste pour l'utilisation dans le traitement des troubles oculaires
|
WO2017089593A1
(fr)
|
2015-11-26 |
2017-06-01 |
Universite Paris Descartes |
Inhibiteurs pour le traitement ou la prévention de l'hypertension artérielle pulmonaire chez des patients présentant une sclérodermie systémique et procédé de diagnostic de ladite maladie
|
JPWO2017094733A1
(ja)
|
2015-11-30 |
2018-09-13 |
日産化学株式会社 |
分子標的医薬に結合するdnaアプタマー及びそれを用いる分子標的医薬の検出方法
|
GB201522186D0
(en)
|
2015-12-16 |
2016-01-27 |
Singapore Health Services Pte Ltd And Nat University Of Singapore The |
Treatment of fibrosis
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
DE102016100039A1
(de)
|
2016-01-04 |
2017-07-06 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
α6-Integrin bindendes DNA-Aptamer
|
US10596367B2
(en)
|
2016-01-13 |
2020-03-24 |
Setpoint Medical Corporation |
Systems and methods for establishing a nerve block
|
US11471681B2
(en)
|
2016-01-20 |
2022-10-18 |
Setpoint Medical Corporation |
Batteryless implantable microstimulators
|
WO2017127756A1
(fr)
|
2016-01-20 |
2017-07-27 |
Setpoint Medical Corporation |
Commande de stimulation vagale
|
WO2017127758A1
(fr)
|
2016-01-20 |
2017-07-27 |
Setpoint Medical Corporation |
Microstimulateurs implantables et systèmes de recharge par induction
|
AU2017210042B2
(en)
|
2016-01-20 |
2021-01-21 |
396419 B.C. Ltd. |
Compositions and methods for inhibiting Factor D
|
CN113970589A
(zh)
|
2016-01-22 |
2022-01-25 |
普度研究基金会 |
带电质量标记系统
|
US10583304B2
(en)
|
2016-01-25 |
2020-03-10 |
Setpoint Medical Corporation |
Implantable neurostimulator having power control and thermal regulation and methods of use
|
EP3998281A1
(fr)
|
2016-02-05 |
2022-05-18 |
Orionis Biosciences BV |
Agents de liaison au cd8
|
CN116008563A
(zh)
|
2016-02-08 |
2023-04-25 |
私募蛋白质体操作有限公司 |
非酒精性脂肪肝疾病(nafld)和非酒精性脂肪性肝炎(nash)生物标记及其用途
|
EP3426278B1
(fr)
|
2016-03-07 |
2024-01-03 |
Vib Vzw |
Anticorps à domaine unique ciblant cd20
|
CN109715802A
(zh)
|
2016-03-18 |
2019-05-03 |
卡里斯科学公司 |
寡核苷酸探针及其用途
|
WO2017180871A1
(fr)
|
2016-04-13 |
2017-10-19 |
Purdue Research Foundation |
Systèmes et procédés pour isoler une cible dans un piège a ions
|
KR20230088514A
(ko)
|
2016-04-14 |
2023-06-19 |
프레드 허친슨 캔서 센터 |
표적화 핵산 나노수송체를 이용하여 치료 세포를 프로그램화하기 위한 조성물 및 방법
|
WO2017187426A1
(fr)
|
2016-04-29 |
2017-11-02 |
Aptamir Therapeutics, Inc. |
Inhibition de l'arnmi mir-22 par apt-110
|
EP3455378A1
(fr)
|
2016-05-10 |
2019-03-20 |
Viasphere, LLC |
Compositions et procédés d'identification, de quantification et/ou de caractérisation d'un analyte
|
JP7105200B2
(ja)
|
2016-05-13 |
2022-07-22 |
オリオニス バイオサイエンシズ ビーブイ |
標的突然変異体インターフェロン-ベータおよびその使用
|
WO2017194782A2
(fr)
|
2016-05-13 |
2017-11-16 |
Orionis Biosciences Nv |
Ciblage thérapeutique de structures non cellulaires
|
US11293017B2
(en)
|
2016-05-25 |
2022-04-05 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
WO2017210476A1
(fr)
|
2016-06-01 |
2017-12-07 |
Duke University |
Biocapteurs ne s'encrassant pas
|
US10829563B2
(en)
|
2016-06-16 |
2020-11-10 |
INSERM (Institute National de la Santé et de la Recherche Médicale) |
Method of screening a candidate compound for activity as an elastase 2A (ELA2A) inhibitor
|
EP3263706A1
(fr)
|
2016-06-28 |
2018-01-03 |
Centre National De La Recherche Scientifique (Cnrs) |
Agents ciblant le snat7 pour le traitement de maladies associé à la reprogrammation du métabolisme cellulaire
|
CN110312808A
(zh)
|
2016-06-30 |
2019-10-08 |
拜欧亿思有限公司 |
双链核酸信号探针以及利用上述双链核酸信号探针的靶分子检测方法
|
CA3027626A1
(fr)
|
2016-07-01 |
2018-01-04 |
Somalogic, Inc. |
Oligonucleotides comprenant des nucleosides modifies
|
EP3264092A1
(fr)
|
2016-07-01 |
2018-01-03 |
Centogene AG |
Utilisation de gb1 en tant que cible thérapeutique
|
RS62011B1
(sr)
|
2016-07-15 |
2021-07-30 |
Acceleron Pharma Inc |
Kompozicije koje sadrže polipeptide actriia za upotrebu u lečenju plućne hipertenzije
|
US11041863B2
(en)
|
2016-07-21 |
2021-06-22 |
Retinal Solutions Llc |
Frizzled-4 mutation indicator of retinopathy and intrauterine growth restriction
|
KR20190040972A
(ko)
|
2016-07-27 |
2019-04-19 |
악셀레론 파마 인코포레이티드 |
골섬유증 치료 방법 및 조성물
|
EP3491135A1
(fr)
|
2016-07-28 |
2019-06-05 |
Laboratoire Français du Fractionnement et des Biotechnologies |
Procédé d'obtention d'aptamères
|
US9927441B1
(en)
|
2016-07-29 |
2018-03-27 |
X Development Llc |
Combinatorial methods for aptamer based proteomics
|
FI3494229T3
(fi)
|
2016-08-03 |
2024-01-29 |
Meiragtx Uk Ii Ltd |
Suuren suorituskyvyn solupohjainen seulonta aptameereille
|
EP3502232A4
(fr)
|
2016-08-22 |
2020-04-01 |
Nissan Chemical Corporation |
Matériau d'échafaudage cellulaire utilisant un aptamère d'acide nucléique se liant à l'e-cadhérine
|
CA3035378A1
(fr)
|
2016-09-01 |
2018-03-08 |
Mayo Foundation For Medical Education And Research |
Compositions d'agents de liaison et de porteuses pd-l1 pour le traitement de cancers
|
US11160876B2
(en)
|
2016-09-01 |
2021-11-02 |
Mayo Foundation For Medical Education And Research |
Methods and compositions for targeting t-cell cancers
|
US11311631B2
(en)
|
2016-09-06 |
2022-04-26 |
Mayo Foundation For Medical Education And Research |
Paclitaxel-albumin-binding agent compositions and methods for using and making the same
|
WO2018067546A1
(fr)
|
2016-10-03 |
2018-04-12 |
President And Fellows Of Harvard College |
Administration d'arn thérapeutiques par le biais de microvésicules à arrdc1
|
CN110177563A
(zh)
|
2016-10-04 |
2019-08-27 |
阿斯克雷佩西治疗公司 |
用于激活tie2信号传导的化合物和方法
|
WO2018067878A1
(fr)
|
2016-10-05 |
2018-04-12 |
Abbott Laboratories |
Dispositifs et procédés d'analyse d'échantillon
|
AU2017340504A1
(en)
|
2016-10-05 |
2019-04-11 |
Acceleron Pharma, Inc. |
Compositions and method for treating kidney disease
|
CN109863396B
(zh)
|
2016-10-05 |
2021-11-05 |
雅培实验室 |
用于样品分析的装置和方法
|
EP3525782B1
(fr)
|
2016-10-14 |
2023-12-06 |
CNS Biosciences, Inc. |
Traitement d'une douleur neuropathique chez des individus souffrant d'une blessure à la moelle épinière
|
JP2019535249A
(ja)
|
2016-10-24 |
2019-12-12 |
バイオイズ カンパニー リミテッド |
TNF−α結合アプタマー及びその治療的用途
|
ES2917000T3
(es)
|
2016-10-24 |
2022-07-06 |
Orionis Biosciences BV |
Interferón-gamma mutante diana y usos del mismo
|
EP3315125A1
(fr)
|
2016-10-31 |
2018-05-02 |
Silence Therapeutics (London) Ltd |
Formulation de nanoparticules lipidiques
|
WO2018084594A1
(fr)
|
2016-11-02 |
2018-05-11 |
김성천 |
Procédé d'analyse quantitative de clusters de protéines cibles à l'aide d'un séquençage de nouvelle génération et son utilisation
|
EP3332812A1
(fr)
|
2016-12-07 |
2018-06-13 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Ensemble à base d'acide nucléique et utilisation de l'ensemble dans la thérapie du cancer
|
WO2018115083A1
(fr)
|
2016-12-21 |
2018-06-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Méthode de traitement de maladies intestinales telles que le syndrome de l'intestin irritable (sii)
|
US11648200B2
(en)
|
2017-01-12 |
2023-05-16 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
WO2018136827A1
(fr)
|
2017-01-20 |
2018-07-26 |
Vitrisa Therapeutics, Inc. |
Compositions à boucle en épingle à cheveux et procédés pour inhiber le facteur d
|
US10906985B2
(en)
|
2017-02-06 |
2021-02-02 |
Orionis Biosciences, Inc. |
Targeted engineered interferon and uses thereof
|
KR102642385B1
(ko)
|
2017-02-06 |
2024-03-04 |
오리오니스 바이오사이언시스 엔브이 |
표적화된 키메라 단백질 및 이의 용도
|
US11246911B2
(en)
|
2017-02-07 |
2022-02-15 |
Vib Vzw |
Immune-cell targeted bispecific chimeric proteins and uses thereof
|
WO2018156658A1
(fr)
|
2017-02-21 |
2018-08-30 |
MEIRAGTX, UK II Limited |
Régulation d'expression génique par modulation médiée par aptamère de l'accessibilité de signaux de polyadénylation
|
US11554097B2
(en)
|
2017-05-15 |
2023-01-17 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
WO2019005503A1
(fr)
|
2017-06-29 |
2019-01-03 |
Rutgers, The State University Of New Jersey |
Compositions et procédés ciblant la signalisation g12 en vue d'une thérapie bronchodilatatrice
|
US11680083B2
(en)
|
2017-06-30 |
2023-06-20 |
Duke University |
Order and disorder as a design principle for stimuli-responsive biopolymer networks
|
EP3428184A1
(fr)
|
2017-07-09 |
2019-01-16 |
Universitätsklinikum Hamburg-Eppendorf |
Moyens de traitement d'une maladie cardiovasculaire
|
US11674959B2
(en)
|
2017-08-03 |
2023-06-13 |
The Johns Hopkins University |
Methods for identifying and preparing pharmaceutical agents for activating Tie1 and/or Tie2 receptors
|
AU2018316205A1
(en)
|
2017-08-09 |
2020-02-06 |
The Procter & Gamble Company |
Aptamers for oral care applications
|
WO2019036470A1
(fr)
|
2017-08-14 |
2019-02-21 |
Setpoint Medical Corporation |
Test de dépistage pour stimulation du nerf vague
|
US10934549B2
(en)
|
2017-08-18 |
2021-03-02 |
University Of Iowa Research Foundation |
Nucleic acid aptamers
|
JP7330174B2
(ja)
|
2017-09-20 |
2023-08-21 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
オートファジーをモジュレーションするための方法及び医薬組成物
|
NL2019739B1
(en)
|
2017-10-16 |
2019-04-23 |
Academisch Ziekenhuis Leiden |
Means and methods for treating muscle degeneration
|
US11473089B2
(en)
|
2017-11-09 |
2022-10-18 |
Ribomic Inc. |
Aptamer for ADAMTS5 and use for aptamer for ADAMTS5
|
WO2019107532A1
(fr)
|
2017-11-30 |
2019-06-06 |
株式会社リボミック |
Aptamère anti-chymase, et son utilisation
|
US20200332296A1
(en)
|
2017-12-28 |
2020-10-22 |
Nuclixbio |
Aptamer template and method for preparing aptamer by using same
|
EP3521828A1
(fr)
|
2018-01-31 |
2019-08-07 |
Centogene AG |
Procédé pour le diagnostic de l' dème de quincke héréditaire
|
US11896643B2
(en)
|
2018-02-05 |
2024-02-13 |
Orionis Biosciences, Inc. |
Fibroblast binding agents and use thereof
|
FI3762004T3
(fi)
|
2018-03-05 |
2023-12-11 |
Klinikum Rechts Der Isar Der Technischen Univ Muenchen |
Kasvainten hoitaminen onkolyyttisen adenoviruksen ja CDK4/6-inhibiittorin yhdistelmällä
|
US10481155B2
(en)
|
2018-03-09 |
2019-11-19 |
Somalogic, Inc. |
Proteomic assay using quantum sensors
|
WO2019175384A2
(fr)
|
2018-03-16 |
2019-09-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Peptides antigéniques dérivés de l'urocortine 3 et leurs utilisations pour le diagnostic et le traitement du diabète de type 1
|
EP3765065A2
(fr)
|
2018-03-16 |
2021-01-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Peptides antigéniques dérivés de sécrétogranine v et leurs utilisations pour le diagnostic et le traitement du diabète de type 1
|
EP3765064A1
(fr)
|
2018-03-16 |
2021-01-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Peptides antigéniques dérivés de pcsk2 et leurs utilisations pour le diagnostic et le traitement du diabète de type 1
|
WO2019202448A1
(fr)
|
2018-04-16 |
2019-10-24 |
University Of Cape Town |
Biomarqueur de protéomique à trois protéines pour la détermination prospective du risque de développement de tuberculose active
|
US11660443B2
(en)
|
2018-04-20 |
2023-05-30 |
The Feinstein Institutes For Medical Research |
Methods and apparatuses for reducing bleeding via electrical trigeminal nerve stimulation
|
FR3081169B1
(fr)
|
2018-05-15 |
2020-06-19 |
Messenger Biopharma |
Substitution de la coiffe des arn messagers par deux sequences d'arn introduites a leur extremite 5'
|
BR112020024715A2
(pt)
|
2018-06-04 |
2021-03-23 |
Avon Products. Inc. |
biomarcadores proteicos para identificar e tratar o envelhecimento da pele e afecções cutâneas
|
US11384357B2
(en)
|
2018-06-29 |
2022-07-12 |
The Procter And Gamble Company |
Aptamers for personal care applications
|
MX2020014143A
(es)
|
2018-06-29 |
2021-03-25 |
Procter & Gamble |
Aptameros para aplicaciones de cuidado del cabello.
|
WO2020028806A1
(fr)
|
2018-08-02 |
2020-02-06 |
Duke University |
Protéines de fusion à double agoniste
|
US11260229B2
(en)
|
2018-09-25 |
2022-03-01 |
The Feinstein Institutes For Medical Research |
Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
|
WO2020069565A1
(fr)
|
2018-10-02 |
2020-04-09 |
WearOptimo Pty Ltd |
Système de mesure
|
US20210317456A1
(en)
|
2018-10-15 |
2021-10-14 |
Somalogic, Inc. |
Nucleic Acid Compounds for Binding Immunoglobulin G
|
WO2020079248A1
(fr)
|
2018-10-19 |
2020-04-23 |
Neoneuro |
Détection précoce de précurseur de la maladie d'alzheimer
|
WO2020117914A1
(fr)
|
2018-12-04 |
2020-06-11 |
Roche Sequencing Solutions, Inc. |
Codage à barres quantique spatialement orienté de cibles cellulaires
|
WO2020115223A1
(fr)
|
2018-12-05 |
2020-06-11 |
Katholieke Universiteit Leuven |
S100a4 utilisable en tant que marqueur de traitement par la spironolactone, la pioglitazone et la metformine
|
CN113164485A
(zh)
|
2018-12-20 |
2021-07-23 |
Ksq治疗公司 |
被取代的吡唑并嘧啶和被取代的嘌呤以及其作为泛素特异性加工蛋白酶1(usp1)抑制剂的用途
|
WO2020144535A1
(fr)
|
2019-01-08 |
2020-07-16 |
Aduro Biotech Holdings, Europe B.V. |
Méthodes et compositions de traitement de myélome multiple
|
US11883401B2
(en)
|
2019-01-08 |
2024-01-30 |
Duke University |
Compositions for the treatment of pathogenic- and/or chemical-induced lung injury and for the treatment of cancer and methods of using same
|
CA3126322A1
(fr)
|
2019-01-21 |
2020-07-30 |
Singapore Health Services Pte. Ltd. |
Traitement d'hepatotoxicite
|
CN113661175A
(zh)
|
2019-02-15 |
2021-11-16 |
整体分子公司 |
包含共同轻链的抗体及其用途
|
KR20210128443A
(ko)
|
2019-02-15 |
2021-10-26 |
인테그럴 몰큘러 인코포레이티드 |
클라우딘 6 항체 및 이의 용도
|
GB201902419D0
(en)
|
2019-02-22 |
2019-04-10 |
Singapore Health Serv Pte Ltd |
Treatment of kidney injury
|
AU2020245346A1
(en)
|
2019-03-22 |
2021-09-09 |
Somalogic Operating Co., Inc. |
Reducing intersample analyte variability in complex biological matrices
|
WO2020201521A1
(fr)
|
2019-04-04 |
2020-10-08 |
Carmentix Pte. Ltd. |
Paires de biomarqueurs d'accouchement avant terme
|
WO2020201520A1
(fr)
|
2019-04-04 |
2020-10-08 |
Carmentix Pte. Ltd. |
Paires de biomarqueurs permettant de prédire un accouchement avant terme
|
EP3946332A1
(fr)
|
2019-04-05 |
2022-02-09 |
Université de Bretagne Occidentale |
Inhibiteurs du récepteur 2 activé par une protéase pour le traitement d'une neuropathie sensorielle induite par une intoxication neurotoxique marine
|
CA3134968A1
(fr)
|
2019-04-16 |
2020-10-22 |
Juan Esteban Velasquez |
Aptameres pour applications de controle des odeurs
|
CA3146344A1
(fr)
|
2019-05-03 |
2020-11-12 |
Singapore Health Services Pte. Ltd. |
Traitement et prevention de maladies metaboliques
|
GB201906291D0
(en)
|
2019-05-03 |
2019-06-19 |
Singapore Health Serv Pte Ltd |
Treatment and prevention of metabolic diseases
|
US20220260585A1
(en)
|
2019-05-17 |
2022-08-18 |
Somalogic Operating Co., Inc. |
Controlling Intersample Analyte Variability in Complex Biological Matrices
|
GB201908544D0
(en)
|
2019-06-14 |
2019-07-31 |
Nat Univ Singapore |
Treatment and prevention of disease mediated by wwp2
|
US11198908B2
(en)
|
2019-06-17 |
2021-12-14 |
Biorchestra Co., Ltd. |
Method for diagnosis of Alzheimer's disease using microRNA
|
KR102113078B1
(ko)
|
2019-07-05 |
2020-05-20 |
광주과학기술원 |
압타머의 선별 방법
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
SG10201906637UA
(en)
|
2019-07-17 |
2021-02-25 |
Agency Science Tech & Res |
Treatment/prevention of disease by linc complex inhibition
|
WO2021019196A1
(fr)
|
2019-07-31 |
2021-02-04 |
University Of Dundee |
Biodétection d'analytes
|
WO2021024020A1
(fr)
|
2019-08-06 |
2021-02-11 |
Astellas Pharma Inc. |
Polythérapie impliquant des anticorps dirigés contre la claudine 18.2 et inhibiteurs de point de contrôle immunitaire pour le traitement du cancer
|
EP4010707A1
(fr)
|
2019-08-07 |
2022-06-15 |
Abbott Laboratories |
Méthodes de détection de substances interférant avec une analyse et d'augmentation de l'échelle dynamique
|
JP2022543618A
(ja)
|
2019-08-07 |
2022-10-13 |
アボット・ラボラトリーズ |
多重化のための化学発光化合物
|
KR20220057534A
(ko)
|
2019-09-03 |
2022-05-09 |
소마로직 오퍼레이팅 컴퍼니, 인코포레이티드 |
심혈관 위험 사건 예측 및 이의 용도
|
KR20220079551A
(ko)
|
2019-09-05 |
2022-06-13 |
클리니쿰 레히츠 데어 이자르 데어 테크니쉔 우니베르지테트 뮌헨 |
종양 세포 붕괴성 아데노바이러스, cdk4/6 억제제 및 추가의 치료 활성제의 조합물에 의한 종양의 치료
|
EP4045656A1
(fr)
|
2019-10-16 |
2022-08-24 |
SomaLogic Operating Co., Inc. |
Composés d'acide nucléique qui se lient à la protéine i du gène inductible par l'acide rétinoïque
|
MX2022007680A
(es)
|
2019-12-20 |
2022-09-26 |
Curevac Ag |
Nanoparticulas lipidicas para administracion de acidos nucleicos.
|
KR20220123236A
(ko)
|
2020-01-10 |
2022-09-06 |
소마로직 오퍼레이팅 컴퍼니, 인코포레이티드 |
손상된 당내성 결정 방법
|
KR20220140727A
(ko)
|
2020-02-10 |
2022-10-18 |
소마로직 오퍼레이팅 컴퍼니, 인코포레이티드 |
비알코올성 지방간염 (nash) 바이오마커 및 이의 용도
|
WO2021178923A1
(fr)
|
2020-03-06 |
2021-09-10 |
Drinksavvy, Inc. |
Dispositifs et procédés de détection d'un analyte cible d'intérêt
|
US20230096625A1
(en)
|
2020-03-10 |
2023-03-30 |
Abbott Laboratories |
Method for droplet loading into nanowells
|
GB202004514D0
(en)
|
2020-03-27 |
2020-05-13 |
Inst De Medicina Molecular Joaeo Lobo Antunes |
Treatment of Immunosuppressive Cancer
|
GB2594094A
(en)
|
2020-04-17 |
2021-10-20 |
Pockit Diagnostics Ltd |
Method for diagnosing stroke caused by large vessel occlusion
|
CN115997020A
(zh)
|
2020-05-07 |
2023-04-21 |
因特欧力多公司 |
新的核酸配体及其鉴定方法
|
US11938324B2
(en)
|
2020-05-21 |
2024-03-26 |
The Feinstein Institutes For Medical Research |
Systems and methods for vagus nerve stimulation
|
US20230235333A1
(en)
|
2020-06-17 |
2023-07-27 |
Ribomic Inc |
Aptamer for il-21 and use thereof
|
GB202009292D0
(en)
|
2020-06-18 |
2020-08-05 |
Singapore Health Serv Pte Ltd |
Treatment and prevention of disease caused by type IV collagen dysfunction
|
MX2022016049A
(es)
|
2020-06-25 |
2023-02-09 |
Procter & Gamble |
Aptameros para aplicaciones para el cuidado personal de la salud.
|
KR20230035576A
(ko)
|
2020-07-07 |
2023-03-14 |
비온테크 에스이 |
Hpv 양성 암 치료용 rna
|
WO2022038521A1
(fr)
|
2020-08-18 |
2022-02-24 |
Regenacellx.SL |
Compositions et procédés de détection de la protéine de spicule du sras-cov-2
|
EP4208204A1
(fr)
|
2020-09-02 |
2023-07-12 |
Mayo Foundation for Medical Education and Research |
Complexes anticorps-nanoparticules et leurs procédés de fabrication et méthodes d'utilisation
|
EP4225922A1
(fr)
|
2020-10-07 |
2023-08-16 |
Centre National de la Recherche Scientifique (CNRS) |
Procédé de sélection d'aptamères, riborégulateurs et désoxyriborégulateurs
|
US20230393146A1
(en)
|
2020-10-20 |
2023-12-07 |
Somalogic Operating Co., Inc. |
Cardiovascular Event Risk Prediction
|
GB202017244D0
(en)
|
2020-10-30 |
2020-12-16 |
Nat Univ Singapore |
Methods to extend health-span and treat age-related diseases
|
TW202233621A
(zh)
|
2020-10-30 |
2022-09-01 |
美商Ksq治療公司 |
經取代吡唑并嘧啶之固態形式及其用途
|
CN112779320B
(zh)
*
|
2020-12-04 |
2023-07-14 |
深圳市易基因科技有限公司 |
多区域dna甲基化检测探针设计及其检测方法
|
EP4259279A1
(fr)
|
2020-12-14 |
2023-10-18 |
Regeneron Pharmaceuticals, Inc. |
Méthodes de traitement de troubles métaboliques et de maladies cardiovasculaires avec des inhibiteurs de la sous-unité bêta e de l'inhibine (inhbe)
|
WO2022131350A1
(fr)
|
2020-12-18 |
2022-06-23 |
タグシクス・バイオ株式会社 |
Désoxyribonucléoside ou désoxyribonucléotide possédant une nouvelle base artificielle pouvant être utilisée pour le criblage d'aptamère d'adn, et acide nucléique le contenant
|
WO2022135667A1
(fr)
|
2020-12-21 |
2022-06-30 |
BioNTech SE |
Arn thérapeutique pour le traitement du cancer
|
TW202245808A
(zh)
|
2020-12-21 |
2022-12-01 |
德商拜恩迪克公司 |
用於治療癌症之治療性rna
|
WO2022135666A1
(fr)
|
2020-12-21 |
2022-06-30 |
BioNTech SE |
Programme de traitement faisant intervenir des protéines cytokines
|
WO2022162015A1
(fr)
|
2021-01-26 |
2022-08-04 |
Universite Brest Bretagne Occidentale |
Nouveaux variants d'épissage de stim1 et leurs utilisations
|
TW202304506A
(zh)
|
2021-03-25 |
2023-02-01 |
日商安斯泰來製藥公司 |
涉及抗claudin 18.2抗體的組合治療以治療癌症
|
EP4323374A1
(fr)
|
2021-04-13 |
2024-02-21 |
SomaLogic Operating Co., Inc. |
Nucléosides modifiés
|
WO2022221496A1
(fr)
|
2021-04-14 |
2022-10-20 |
Somalogic Operating Co., Inc. |
Composés d'acides nucléiques se liant aux protéines de coronavirus
|
US11578320B2
(en)
|
2021-04-27 |
2023-02-14 |
Singular Genomics Systems, Inc. |
High density sequencing and multiplexed priming
|
WO2022266031A2
(fr)
|
2021-06-15 |
2022-12-22 |
Somalogic Operating Co., Inc. |
Prédiction de l'insuffisance rénale et ses utilisations
|
WO2023278502A1
(fr)
|
2021-06-30 |
2023-01-05 |
Somalogic Operating Co., Inc. |
Détermination de la santé rénale et utilisations associées
|
KR20240046323A
(ko)
|
2021-07-13 |
2024-04-08 |
비온테크 에스이 |
암에 대한 병용 요법에 있어서 cd40 및 cd137에 대한 다중특이 결합제
|
WO2023006765A1
(fr)
|
2021-07-26 |
2023-02-02 |
Boehringer Ingelheim International Gmbh |
Traitement et prévention d'une maladie hépatique alcoolique
|
KR20230022813A
(ko)
|
2021-08-06 |
2023-02-16 |
인터올리고 주식회사 |
비천연 핵산 리간드 및 이의 용도, 및 이를 유효성분으로 포함하는 암의 치료를 위한 약학적 조성물
|
CA3230031A1
(fr)
|
2021-09-03 |
2023-03-09 |
Patrick Baumhof |
Nouvelles nanoparticules lipidiques pour l'administration d'acides nucleiques
|
CA3231700A1
(fr)
|
2021-09-10 |
2023-03-16 |
Guardian Therapeutics, Llc |
Conjugues acides gras d'acides nucleiques
|
CA3234647A1
(fr)
|
2021-10-06 |
2023-04-13 |
Genmab A/S |
Agents de liaison multispecifiques diriges contre pd-l1 et cd137 en combinaison
|
WO2023057535A1
(fr)
|
2021-10-06 |
2023-04-13 |
Genmab A/S |
Agents de liaison multispécifiques contre pd-l1 et cd137 en combinaison avec des anticorps anti-pd-1 pour le traitement de cancers
|
WO2023059854A1
(fr)
|
2021-10-07 |
2023-04-13 |
Somalogic Operating Co., Inc. |
Prédiction du cancer du poumon et utilisations associées
|
TW202333802A
(zh)
|
2021-10-11 |
2023-09-01 |
德商拜恩迪克公司 |
用於肺癌之治療性rna(二)
|
WO2023066881A1
(fr)
|
2021-10-18 |
2023-04-27 |
Astrazeneca Ab |
Inhibition de map3k15 pour le traitement et la prévention du diabète
|
WO2023083439A1
(fr)
|
2021-11-09 |
2023-05-19 |
BioNTech SE |
Agoniste de tlr7 et combinaisons pour le traitement du cancer
|
WO2023114802A1
(fr)
|
2021-12-14 |
2023-06-22 |
The Procter & Gamble Company |
Aptamères pour applications de soins de santé personnels
|
WO2023111196A1
(fr)
|
2021-12-16 |
2023-06-22 |
Singapore Health Services Pte. Ltd. |
Traitement et prévention d'une maladie glomérulaire
|
WO2023141248A1
(fr)
|
2022-01-21 |
2023-07-27 |
Somalogic Operating Co., Inc. |
Procédés d'évaluation de qualité d'échantillons
|
WO2023154452A1
(fr)
|
2022-02-11 |
2023-08-17 |
Waypoint Bio, Inc. |
Sondes de coloration cellulaire pour la détection d'analytes
|
WO2023183873A1
(fr)
|
2022-03-24 |
2023-09-28 |
Mensura Health Inc. |
Aptamères et leurs utilisations
|
WO2023211770A1
(fr)
|
2022-04-24 |
2023-11-02 |
Somalogic Operating Co., Inc. |
Procédés d'évaluation de la qualité d'un échantillon
|
WO2023211773A1
(fr)
|
2022-04-24 |
2023-11-02 |
Somalogic Operating Co., Inc. |
Procédés d'évaluation de qualité d'échantillons
|
WO2023211771A1
(fr)
|
2022-04-24 |
2023-11-02 |
Somalogic Operating Co., Inc. |
Procédés d'évaluation de la qualité d'un échantillon
|
WO2023211769A1
(fr)
|
2022-04-24 |
2023-11-02 |
Somalogic Operating Co., Inc. |
Procédés pour évaluater la qualité d'un échantillon
|
WO2023235858A1
(fr)
|
2022-06-03 |
2023-12-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Composé antiviral modifié pénétrant dans les cellules
|
WO2024008755A1
(fr)
|
2022-07-04 |
2024-01-11 |
Vib Vzw |
Anticorps de traversée de barrière de fluide céphalorachidien
|
WO2024015486A1
(fr)
|
2022-07-14 |
2024-01-18 |
Somalogic Operating Co., Inc. |
Procédés d'évaluation de la qualité d'un échantillon
|
WO2024015485A1
(fr)
|
2022-07-14 |
2024-01-18 |
Somalogic Operating Co., Inc. |
Procédés d'évaluation du risque de démence
|
WO2024026474A1
(fr)
|
2022-07-29 |
2024-02-01 |
Regeneron Pharmaceuticals, Inc. |
Compositions et méthodes d'administration médiée par le récepteur de la transferrine (tfr) au cerveau et au muscle
|
WO2024030432A1
(fr)
|
2022-08-01 |
2024-02-08 |
Gensaic, Inc. |
Particules dérivées de phages thérapeutiques
|
GB202212077D0
(en)
|
2022-08-18 |
2022-10-05 |
Tribune Therapeutics Ab |
Agents that inhibit ccn ligand-induced signalling for treating disease
|
WO2024064322A2
(fr)
|
2022-09-23 |
2024-03-28 |
Somalogic Operating Co., Inc. |
Procédés d'évaluation de l'état d'utilisation de tabac
|
WO2024077118A2
(fr)
|
2022-10-06 |
2024-04-11 |
Bicara Therapeutics Inc. |
Protéines multispécifiques et procédés associés
|